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ABSTRACT 
Lepera, Michael Anthony, M.S., Pharmacology/Toxicology Masters Program, 
Wright State University, Department of Pharmacology and Toxicology 2011. 
Response of Monovalent Cation Transporters to Pro-apoptotic Protein Kinase C 
Modulators in Human Lens Epithelial Cells. 
 
 
 Protein kinase inhibition by staurosporine causes apoptotic volume 
decrease involving potassium (K) channels in immortalized human B3 lens 
epithelial cells (LECs). Here, the effect of two pro-apoptotic protein kinase C 
(PKC) inhibitors [12-O-tetradecanoyl-phorbol-13-acetate (TPA) and chelerythrine 
(CET)] were studied on membrane K transport in a fetal human LEC line 
(FHL124) by western blotting, immunofluorescence, ion flux, ATP, apoptosis, and 
biotinylation assays. Long term TPA exposure (0-6 h) inhibited 75% of Na-K-2Cl 
cotransport (NKCC). In contrast, short term (0-20 min) exposure to 50 µM CET 
reduced Na/K pump and NKCC by >90% and >70%, respectively, without 
retrieval from the membrane into the cytosol, loss of ATP and early signs of 
apoptosis. CET (10-30 µM) decreased cell K by 33%. Results suggest PKC 
modulation through the use of pro-apoptotic agents caused major early 
membrane changes independently affecting K channels, the Na/K pump and 
NKCC function, prior to rise of any significant apoptosis. 
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1. Background and Literature Review 
1.1 Growth and Development of Human Lens Epithelial Cells (HLEC) 
 
 The human lens is formed by surface ectoderm invagination (Krag et al., 
2003).  The lens capsule is formed by the outer most cells of the lens vesicle and 
is surrounded by the basement membrane of the surface ectoderm which acts as 
a barrier for the developing lens to provide protection from bacterial and viral 
invasions (Danysh et al., 2009).  The lens continues to grow throughout life but 
slows down with age. The lens is a very unique structure, as it is the largest 
organ in the body that lacks a direct blood supply.  Blood vessels disperse and 
absorb light whereas a lens devoid of blood supply can support the cornea in 
focusing light on the retina (Mathias et al., 2007).  As a result of the lack of blood 
supply, the lens, over time, has developed its own micro-circulatory system to 
transfer and circulate ions in order to obtain nutrients (Mathias et al., 2007).  After 
invagination, the cells become inverted so that their apical surfaces face inward 
to the lumen and the basal surfaces the basement membrane outward to the 
capsule (Bhat 2001, Krag et al., 2003). The transformation from lens epithelial 
cells (LECs) to lens fibre cells (LFCs) is a crucial stage for the growth and 
development of the lens.  First, posterior LECs must differentiate into primary 
LFCs causing elongation that eradicates the lumen of the lens vesicle.  This 
brings the apical surface of the elongated LFC together with the apical surface of 
the anterior epithelial cells to form the apical interface (Bhat 2001).   
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Figure 1- Early Stages of Lens Development. Surface ectoderm thickens and 
invaginates and compresses to form the lens vesicle LECs differentiate into 
LFCs. (Figure and legend adapted from Bhat 2001). 
 All future growth and development of the lens rests solely on the anterior 
LECs since the posterior surface is now deficient of LECs.  The epithelial cells 
under the anterior lens form a monolayer of cells, which are essential for the 
overall transparency and health of the lens, and remain undifferentiated with little 
cell division throughout life (Li et al., 1995, Duncan et al., 1997, Krag et al., 2003, 
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Danysh et al., 2009).  Only epithelial cells near the equator divide before 
transforming into secondary LFCs that make up the body of the lens (Beebe et 
al., 1990, Duncan et al., 1997, Krag et al., 2003, Danysh et al., 2009).  This 
process is driven by an increase in cell volume that causes morphological 
changes such as elongation, loss of intracellular membrane-bound organelles, 
degradation of the nucleus, and causes the LFCs to stop dividing (Beebe et al., 
1990, Andley et al., 1994).  Once the intracellular organelles are lost, light 
scattering is reduced but the LFCs must survive without protein synthesis for the 
rest of its lifetime.  As elongation continues, the LFCs become internalized and 
attach to Type IV collagen that runs from the center of the lens to the anterior 
and posterior poles (Mathias et al., 2007).  
1.2. Normal Homeostasis in the Lens 
 
   Volume constancy is an essential part of all living cells requiring 
continuous management of ions and water passage through transporters and 
channels (Lauf et al., 2008).  
 The Na/K pump: Foremost, and like almost all cells, LECs contain high 
intracellular K and low intracellular Na maintained by the Na/K pump (Cui et al., 
2002, Mathias et al., 2007). The Na/K pump is a membrane bound adenosine 
triphosphate (ATP) hydrolase (ATPase), consisting of a ~100 kDa molecular 
mass α subunit (Kaplan 2002) that through ATP-hydrolysis creates above 
electrochemical gradient allowing 2K+ to enter and 3Na+ to leave the cell by a 
ping pong mechanism (Skou 1998 Nobel lecture, reviewed in Glynn 2002, Sachs 
1980, reviewed in Lauf and Adragna 2011). This exchange involves canonical 
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formation of a transient high energy phosphate bond at Asp 369 within the 
catalytic center of the enzyme (reviewed in Lauf and Adragna 2011). The Na/K 
ATPase membrane protein is a heterotrimer consisting of the α catalytic subunit, 
a β subunit for membrane insertion (Feraille et al., 2000) and a regulatory γ 
subunit.  An alteration of the high K/Na ratio may affect the conversion of LECs to 
LFCs. Indeed, correlations have been established between man’s age, lens K/Na 
ratio and cation permeability, and cataract formation (Duncan et al., 1997).  In 
addition to the catalytic phosphorylation site, there is evidence for additional 
phosphorylation by serine (S), threonine (T) and tyrosine (Y) kinases and 
dephosphorylation by S, T and Y phosphatases.  There are 2 PKC 
phosphorylation sites located on the α1 subunit, Ser11 and Ser18 (Feschenko et 
al., 1997) and their phosphorylation is proposed to be required to transport the 
Na/K pump from the cytosol to the membrane (Feschenko et al., 2000). Tyrosine 
phosphorylation at Y416 by a Y-kinase is a mechanism by which the Na/K 
ATPase is proposed to be inactivated during the transition from LECs to LFCs 
(Tamiya et al., 2007).  
 Cell volume regulation mechanisms ensure normal homeostasis in the 
lens, i.e., ion channels (K, Na, Cl), ion exchangers (Na/H, HCO3/Cl), and 
cotransporters (Na-K-2Cl, K-Cl) (Lauf et al., 2006, 2008, Mathias et al., 2007, 
Chimote 2009).  Regulatory volume decrease (RVD) responds to stimuli causing 
cellular water entrance and swelling.  Regulatory volume increase (RVI) 
responds to stimuli causing cellular water loss and shrinkage (Lauf et al., 2008).  
Stretch studies done by Candia et al. (2008) have shown that a change in overall 
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lens volume involving the RVD and RVI mechanisms is required for lens 
accommodation, which is the ability to continuously focus on objects as the 
distances vary (Candia et al., 2008). 
 Together with a multitude of Na/H (NHE) exchanger isoforms, the Na-K-
2Cl cotransporter (NKCC) and the K-Cl cotransporter (KCC) are responsible for 
the control of the volume set point (VSP) of normal cell volume in response to 
different kinase phosphorylation and phosphatase dephosphorylation 
mechanisms (Lauf et al., 2006).  The VSP is defined as “a state between RVD 
and RVI where conservatory and dissipating ion and solute transport activities 
balance each other and are at their lowest activity to maintain cellular steady 
state” (Lauf et al., 2008).  The KCC normalizes cell volume after swelling and is 
activated by dephosphorylation whereas the NKCC counteracts cell shrinkage 
and is activated by phosphorylation (Lauf et al., 2006).  Both sets of 
cotransporters are secondary active transporters in which the cations are coupled 
in a 1:1 ratio with Cl and do not require ATP hydrolysis but instead rely on 
electrochemical gradients established by primary active transport through the 
Na/K pump (Lauf and Adragna 2000, Gamba 2005).  Changes in cell volume are 
due to the movement of Cl in or out of the cell (Gamba 2005).  For example, in 
neurons, NKCC is the primary transporter responsible for high intracellular Cl 
during early development but is down regulated after birth. In contrast, the KCC 
is absent during early development but active after birth and into adulthood 
(Delpire 2000, Gamba 2005).  
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1.3. RVD and RVI 
 
 In animal cells, osmotic swelling triggers K and Cl efflux through channels 
and transporters to return them to their normal size.  K efflux alone causes 
membrane hyperpolarization that keeps K in the cells so Cl efflux is needed in 
parallel to regulate cell volume (Mongin et al., 2001).  Aiding in RVD are the four 
isoforms of electroneutral K-Cl cotransporters (KCC) and their spliced variants 
activated by PP1 causing dephosphorylation and inactivated through 
phosphorylation by a kinase (Jennings et al., 1990).  Strange et al. (2000) 
showed that mutations of a C-terminus KCC2 tyrosine kinase residue were 
detrimental to the cotransporter function (Strange et al., 2000). Recent evidence 
indicates that the C-terminus of the KCC3 has several S and T phosphorylation 
sites (Rinehart et al., 2009). Truncation of the C-terminus portion of KCC1 
reduces significantly the NEM-induced activation of K-Cl cotransport in HEK293 
transfected cells (Lauf et al., 2001).   Given the chemical driving forces for K and 
Cl, the KCCs generally perform the outward transport of K and Cl that results in 
water loss and ultimately causes the cell to shrink (Flatman et al., 1996, Lauf et 
al., 2000, Gamba 2005).  
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Figure 2- Cell volume regulation.  Water influx due to hyposmotic stress 
causing cell swelling.  RVD restores normal cell volume by an efflux of K, Cl, and 
H2O.  Efflux of water due to hyperosmotic stress causing cell shrinkage.  RVI 
restores normal cell volume by an influx of Na, K, Cl, and H2O.  (Figure and 
legend adapted from Chimote 2009). 
 The KCC1 isoform, located on chromosome 16.q22.1, regulates volume 
homeostasis and is ubiquitously expressed in all cells.  KCC2, located on 
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chromosome 20, occurs in two spliced variants KCC2a and KCC2b.  The latter 
was originally found only in the brain needed to remove intracellular Cl in order to 
assist GABA inhibiting neurons (Payne 1997) and the former also in a human 
LEC line (Lauf et al., FASEB J March 17, 2011 25:657.8).  The KCC3 isoform 
functions as a K buffer and is located on chromosome 15.q13.  It is found in the 
heart, brain, liver, placenta, lung, and pancreas (Lauf et al., 2000, Gamba 2005). 
The KCC4, located on chromosome 5p15, is present in the heart and kidney.  
KCC4 is pH regulated and could possibly play a role in acid-base metabolism 
(Lauf 2000, Gamba 2005).  The KCC1, 3, and 4 but not KCC2 isoforms were 
detected in human lens extracts (Misri et al., 2006).  
Cell swelling also causes activation of Ca-activated K channels, Cl 
channels, K/H and Cl/HCO3 exchangers (Chimote 2009, Mongin et al., 2001, 
Okada 2004).  Ca-activated K channels are divided into 3 groups; the voltage 
independent small conductance (SK), the inwardly rectifying intermediate 
conductance (IK) channel which performs RVD in human LECs (Lauf et al., 
2008), and the voltage dependent big K (BK) conductance (BK) channel (Wang 
et al., 2003).  IK channels work together with the Cl- extruding volume-sensitive 
outwardly rectifying anion channels (VSOR) or volume-regulated anion current 
(VRAC) to normalize cell volume (Okada 2004, Hoffmann et al.,  2007, Chimote 
2009).   
 When cells osmotically shrink, RVI triggers K and Cl influx into the cell and 
closes K channels in order for the cell to return to its normal size (Candia et al., 
2008).  A major player in RVI is the electroneutral NKCC.  The NKCC has been 
9 
 
proposed to be responsible for the inward movement of Na, K, and 2Cl but its 
main role is Cl transport across the cell (Delpire 2000, Tang et al., 2010).  There 
are 2 known isoforms of NKCC, NKCC1 and NKCC2, where NKCC1 is the only 
one found in the lens.  NKCC1 is ubiquitously expressed and is located on 
chromosome 5q23 where it is encoded by the SLC12A gene (Gamba 2005, Tang 
et al., 2010).  In epithelial cells, NKCC1 is localized in the basolateral membrane, 
except in the choroid plexus in which NKCC1 is bound to the apical membrane 
(Gamba 2005).  The NKCC2 isoform, located on chromosome 15, occurs 
primarily in the luminal membrane of the thick ascending limb epithelial cells 
where it is responsible for NaCl reabsorption (Hebert et al., 1984).  In contrast to 
the gliding symmetry model explaining the NaCl reabsorption through NKCC by a 
mechanism of orderly Na-Cl-K-Cl loading and unloading, most recently this 
model has been challenged by proposing that NKCC1 utilizes 1 Na and 1 Cl to 
bind its external aspect while transporting de facto KCl across the plasma 
membrane (Delpire and Gagnon FASEB J March 17, 2011 25:657.12).  As 
opposed to the KCC, phosphorylation stimulates NKCC and dephosphorylation 
inhibits it.  When intracellular chloride concentration falls, the NKCC1 becomes 
phosphorylated and its activation at the basolateral side causes Cl to be secreted 
across the apical membrane through Cl channels.  When the chloride 
concentration increases, NKCC1 becomes dephosphorylated and inhibited 
(Gamba 2005). Ste20 related proline/alanine rich kinase (SPAK) phosphorylation 
along with oxidative stress response 1 (OSR1) phosphorylation increases the 
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activity of NKCC1 in the presence of WNK4 (with no lysine). This activation 
occurs when SPAK binds to WNK4 (Piechotta et al. 2003, Gagnon 2007).  
 
Figure 3- Scheme of SPAK/WNK4 regulation of NKCC1. WNK4 
phosphorylation of SPAK which in turn phosphorylates and activates NKCC1 
(Figure taken from and legend modified from Gagnon et al., 2007). 
 Both SPAK and OSR1 interact with the amino terminus of NKCC1.  
NKCC1 contains two SPAK binding motifs, one of which partially overlaps with 
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the binding site of PP1 on NKCC1 (Piechotta et al., 2002).  However, only one 
site is needed for the activation and regulation of NKCC1 (Gagnon et al., 2007).   
 NKCC2 is primarily present in the kidney, specifically in the apical 
membrane of the ascending loop of Henle (Delpire et al., 1999, Hoffmann et al., 
2007). Also mediating RVI is the activation of Na channels and of the Na/H 
exchange which triggers acidification and activation of Cl/HCO3 exchange.  This 
allows the cells to load with Na and Cl and release H and HCO3 (Mongin et al., 
2001, Okada 2004). 
 1.4. Cataract Formation in the Lens 
 
 Cataract is defined as a loss of transparency (opacification) in the lens and 
is responsible for 42% of all blindness in the world (Kyselova et al., 2004).  This 
is a result of an accumulation of stress and damage over the years leading to the 
improper arrangement or stacking of new LFC over the old ones (Bhat 2001).  
Apoptosis has been thought by many to be an important step in the development 
of cataracts.  Li et al. (1995), demonstrated that apoptosis is indeed associated 
with and precedes cataract formation (Li et al., 1995).  LEC apoptosis can be 
triggered by UV light, oxidative stress, and increased calcium levels (Li et al., 
1995).  Over time, UV-B radiation exposure can cause serious damage to the 
eye by depleting the lens of antioxidants causing lens opacification and the 
development of cataracts (Chandler et al., 2010, Kyselova et al., 2004).  
Apoptosis was shown to be related to the development of anterior polar cataract, 
which is the differentiation of irregularly growing LECs into myofibroblast-like cells 
(Lee et al., 2002).  LFCs rely on transporters to meet their nutritional 
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requirements.  LFC nutrients are driven and maintained by the establishment of a 
Na gradient by the Na-K pump concentrated in the equatorial LECs.  The 
slightest disruption in this gradient leads to a decrease in nutrient availability for 
the LFCs and an increase of oxidative damage leading to the formation of 
nuclear cataracts (Mathias et al., 2007).  Another kind of cataract is the diabetic 
cataract.  With little protein turnover in the lens, diabetes mellitus produces 
cataracts from the overload and metabolic effects of glucose diffusing into the 
lens (Kyselova et al., 2004).  
 Cataract surgery is always an option to improve clouded vision, but there 
are some complications that come with this.  In 1997, it was reported that 30-50% 
of cataract patients developed posterior capsule opacification (PCO) following 
surgery (Duncan et al., 1997).  PCO is a secondary cataract that arises when 
LECs left behind after surgery begin to proliferate, divide and migrate from the 
equator and anterior epithelium to the posterior capsule under the intraocular 
lens impeding vision (Duncan et al., 1997, Wormstone et al., 1997, Liu et al., 
1996, Yadav et al., 2009).   
1.5. Structure and Function of Protein Kinase C (PKC) 
 
 Many cellular and biological processes such as cell proliferation, 
differentiation, apoptosis, and gene activation are dependent on the function of 
the many isoforms of PKC, which are a group of serine/threonine kinases 
(Gutcher et al., 2003, Thodeti et al., 2001, Steinberg 2008).  At least ten PKC 
isoforms have been identified to date and grouped into 3 categories according to 
their structure and second messenger requirements: conventional, novel, and 
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atypical.  All isoforms require phosphatidylserine (PS) for their activation. 
Conventional PKCs are activated by binding diacylglycerol (DAG) in a calcium-
dependent manner, while the novel PKCs bind DAG in a calcium-independent 
manner.  The atypical PKCs only require PS for activation (Mellor et al., 1998, 
Gutcher et al., 2003, Thodeti et al., 2001, Steinberg 2008).  
Table 1- PKC isoform classification and functional requirements 
PKC Isoform Classification Functional Requirements 
 PS DAG 
Conventional α, βI, βII, γ + + 
Novel δ, ε, ζ, ε + + 
Atypical δ, η + - 
 
 All PKC isoforms consist of four conserved domains (C1-C4) and five 
variable domains (V1-V5).  C1 and C2 are membrane binding and make up the 
regulatory domain to keep the enzyme in an inactive state. C3 and C4 make up 
the catalytic domain, which is needed for ATP and substrate binding (Dempsey et 
al., 2000, Gutcher et al., 2003, Steinberg 2008). The C1 domain contains two 
cysteine-rich zinc fingers that bind DAG.  C2 binds calcium.  The C3 domain 
serves as the ATP binding site and the C4 domain is the substrate binding site 
(Gutcher et al., 2003). 
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Figure 4- PKC structure. DAG binds to the cysteine-rich zinc fingers of C1, 
calcium binds to C2, ATP at the C3 region, and C4 is the substrate binding site 
(Figure adapted from Gutcher et al., 2003). 
 
 
 As shown in Figure 5, PKC activation by DAG involves a series of 
signalling cascades that begin with the ligation of cell surface receptors causing 
activation of phospholipase C (PLC) which generates DAG and inositol 
triphosphate (IP3) through the hydrolysis of phosphatidylinositol 4, 5-biphosphate 
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(PIP2).  IP3 departs to the endoplasmic reticulum to mobilize intracellular calcium 
while DAG remains in the plasma membrane to recruit inactive PKC.  In order for 
PKC to be recruited to the membrane there must be phosphorylation of three 
conserved sites in the catalytic domain of PKC to ensure maturity and 
preparation for activation: 1) Phosphorylation in the activation loop of the C-
terminus by 3-phosphoinositide-dependent kinase (PDK-1).  2) 
Autophosphorylation in the hydrophobic region for activation of conventional and 
novel PKC isoforms.   3) PKC is released into the cytosol after the final 
phosphorylation step where it is recognized by the pseudo-substrate region. DAG 
brings PKC into the membrane along with the pseudo substrate region. The 
pseudo-substrate region is displaced, PKC is activated in the membrane, and 
binds to receptors for activated C kinases (RACKs), which are anchoring proteins 
that determine its localisation (Dempsey et al.,  2000, Parekh et al., 2000, Gao et 
al., 2001, Gutcher et al., 2003, Steinberg 2008).  
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Figure 5- PKC activation.  
Figure explained above.  (Figure adapted from Gutcher et al., 2003). 
 PKC isoforms can be considered pro-apoptotic or anti-apoptotic and play 
crucial roles in the cell but it all depends on what cell type the isoform is 
expressed in (Gutcher et al., 2003).  In conjunctival goblet cells, PKCα and PKCε 
are needed for cell proliferation (Shatos et al., 2009).  PKCε and PKCδ are 
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involved in the response of the heart to ischemia and reperfusion, where PKCε is 
cardio-protective and PKCδ causes damage to the myocardium (Murriel et al., 
2003).  PKCε has been shown to be involved in muscle contraction, gene 
expression, and metabolism (Akita 2002).    
 In human leukemia cells, PKCδ phosphorylates p53 which leads to the 
onset of apoptosis (Yoshida et al., 2006).  PKCζ regulates cytoskeleton stability 
and barrier permeability in intestinal epithelial cells (Banan et al., 2004).   PKCζ 
has also been implicated in T-cell activation and proliferation (Carrasco et al., 
2004).  In airway epithelial cells PKCδ binds to F-actin and is needed for the 
regulation of NKCC1 (Liedtke et al., 1997, 2003).  According to this group SPAK 
binds PKCδ and down regulation of SPAK results in a loss of NKCC1 function.  It 
was concluded PKCδ phosphorylates SPAK acting as a mediator for NKCC1 
activation (Smith et al., 2008).  
 Since PKC is involved in so many biological processes, it is important to 
study what happens when a cell is depleted of this very important kinase.  
Pharmacological tools have been developed for this purpose.  Phorbol esters are 
tumor promoters that mimic DAG binding to the C1 domain of PKCs (Brose et al., 
2002).  Belonging to this group of phorbol esters is 12-O-tetradecanoyl-phorbol-
13-acetate (TPA) and phorbol 12-myristate 13-acetate (PMA), which can cause 
cell proliferation or cell arrest depending on the cell type (Isonishi et al., 2000).  It 
has been previously shown, using Madin-Darby canine kidney (MDCK) cells, that 
activation of PKC by PMA retrieves NKCC1 from the membrane to the cytosol 
within 2.5 min through a clathrin-mediated endocytotic pathway: after 15 min 
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most of the NKCC1 vesicles had moved inside the cell (Mykoniatis et al., 2010).  
These authors also observed that F-actin and Na-K-ATPase didn’t move from the 
membrane of the cell when treated with PMA (Mykoniatis et al., 2010).  
 Other pharmacological tools like staurosporine (STP) and naphthalene 
sulfonamides have been shown to induce apoptosis but with little selectivity 
towards PKC (Chmura et al., 2000, Andersson et al., 2000).  The most potent 
and most selective inhibitor for PKC is chelerythrine (CET), a quaternary 
benzophenanthridine alkaloid, which binds to the C3 domain ATP binding site of 
PKCs (Herbert et al., 1990, Lou et al., 2003). Like TPA, STP causes 
redistribution of PKC isoforms from the cytosol to the membrane (Courage et al., 
1995). Inhibition of PKC with these drugs can be detrimental to the cell. In 
HLECs, treatment with STP leads to competition between STP and ATP resulting 
in dephosphorylation of kinases and possibly of the 4-amino pyridine sensitive K 
channel with subsequent K loss, water loss, and apoptosis (Chimote et al., 2010).  
CET is considered a pro-apoptotic agent that triggers the release of cytochrome c 
from the mitochondria by inhibiting BclXL at the BH3 domain (Chan et al., 2003). 
In cardiac myocytes, CET has been shown to produce reactive oxygen species 
leading to the development of apoptosis (Yamamoto et al., 2001).   
1.6. Consequence of PKC inhibition: Apoptosis 
 
 There are many forms of cell death; necrosis, anoikis, and apoptosis to 
name a few, each with its own unique attributes.  Necrotic cell death is energy-
independent and can be attributed to the swelling of cells while anoikis is cell 
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death induced by the detachment of cells from their extracellular matrix (Kroemer 
et al., 2009, Murriel et al., 2003).  
 Apoptosis or programmed cell death occurs normally during development 
or as a response to stress or toxically induced events to remove excess or 
unwanted cells.  Removal of cells during eye development is needed for the 
timely separation of the lens from the future corneal epithelium and for the 
development the retina (Harocopos et al., 1998).  The problem arises when 
uncontrollable cell death occurs.  Apoptosis has been linked to the development 
of cataracts, AIDS, and cancer (Li et al., 1995, Harocopos et al., 1998, Gutcher et 
al., 2003, Lionetto et al., 2010).  There are many indications that a cell has turned 
apoptotic: cell membrane blebbing, cell shrinkage, caspase activation, DNA 
fragmentation, disturbance of membrane asymmetry by the translocation of 
phosphatidylserine (PS) by scramblases from the inner to the outer leaflet of the 
plasma membrane, mitochondrial depolarization, and formation of apoptotic 
bodies (Gutcher et al., 2003, Chimote 2009, Lang et al., 2010, Lionetto et al., 
2010). Potassium (K) has been shown to be an important ion in the regulation of 
apoptosis.  As stated earlier, a normal cell contains high levels of intracellular K.  
When cells start to lose K, this causes apoptotic volume decrease (AVD) with 
subsequent apoptosis (Bortner et al., 2007).   
 Emerging over the years have been the two popular pathways of 
apoptosis, intrinsic and extrinsic.  The intrinsic pathway, also known as the 
mitochondrial pathway, is initiated through disruption within the cell of certain cell 
functions by DNA damage and different kinds of stress signals. In this pathway, 
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damage causes cytochrome c release from the mitochondria and activation of 
caspase-3 through caspase-9 leading to cellular apoptosis (Fulda et al., 2006).  
The extrinsic pathway, also known as the death receptor pathway, is initiated by 
the signalling of receptors outside the cell.  The death receptors include CD95 
and tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL).  
Activation of the death receptors leads to recruitment of the Fas ligand-
associated death domain (FADD) and inactive procaspase-8.  Once bound, 
caspase-8 becomes activated, cleaves effector caspases like caspase-3 and 
stimulates the caspase cascade leading to apoptosis (Fulda et al., 2006).  
 Previous work has shown that apoptotic cell shrinkage induced by the pro-
apoptotic general kinase inhibitor staurosporine (STP) is initiated by apoptotic 
volume decrease (AVD) and mediated by 4-AP-sensitive voltage-gated K 
channels in human lens epithelial cells (Chimote et al., 2010). Although lipid 
changes with PS externalization occurs within 15 min after adding STP to 
HLECs, caspase inhibitors appear without effect on this process suggesting early 
membrane changes including Kv channel activation (Chimote et al., 2010). The 
actual target kinases are unknown nor whether the STP effect includes the 
participation of the so called mitochondrial (intrinsic) pathway of apoptosis. There 
are many protein kinases found throughout the human lens such as 
serine/threonine, tyrosine kinases, MAPK and others, all involved in a wide 
variety of physiological processes. A tyrosine kinase-mediated phosphorylation of 
the Na/K pump has been proposed to be responsible for the Na/K pump 
inactivation during the LEC to the LFC transition (Tamiya et al., 2007). All could 
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be a target for STP, a fungal derivative displacing ATP, but in order to link early 
membrane changes to a particular kinase group, the serine/threonine protein 
kinases C, are of great interest as they are important in the regulation of various 
membrane transport processes. 
 
Figure 6- Proposed Mechanism of STP induced apoptosis 
Proposed scheme of events during AVD. STP inhibits kinases, especially serine 
threonine kinases (1), causing wide-spread dephosphorylation with activation of 
4-AP-sensitive Kv channels (2, 3A) and scramblases (2), with externalization of 
PS from the inner cell surface (3B) and phospholipid randomization (5). The 
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resulting membrane lipid symmetry is accompanied or followed by depolarization 
(4,5) furthering K efflux.  The loss of Ki triggers activation of effector caspases 
(6), DNA fragmentation (7) and cell death. (Figure and legend taken from 
Chimote et al., 2010). 
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2. Rationale and Hypothesis 
 
 Human lens epithelial cells contain at least 4 different protein kinase 
(phosphorylase) PKC isoforms, of which at least two (α and ε) are anti-apoptotic 
and two (δ and ζ) pro-apoptotic. A hallmark of cell volume control is that major K 
transporters such as the Na/K pump, the Na-K-2Cl (NKCC) and K-Cl (KCC) 
cotransporters are under reciprocal phosphorylation / dephosphorylation control 
during their activation and inactivation.  There is evidence from other cell systems 
that at least one PKC isoform contributes via another kinase to the 
phosphorylation and hence activation of NKCC (Liedtke et al., 2002, 2003), and 
another PKC might phosphorylate the Na/K pump (Feraille et al., 1999) 
suggesting a crucial role of PKCs in the regulation of membrane transport.  
The following hypothesis is proposed: 
In lens epithelial cells various pro-apoptotic stressors target PKC kinases 
and thus modify important membrane transport functions causing loss of 
cellular K through channels and KCC or inhibition of inward K transport by 
the Na/K pump and the NKCC, resulting in activation of the caspase 
cascade followed by apoptosis associated with membrane phospholipid 
changes, mitochondrial depolarization, and DNA fragmentation. These 
changes affect the normal cellular homeostasis of lens epithelial cells and 
their ultimate trans-differentiation into lens fiber cells and thus might 
contribute to cataract formation.  
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2.1. Specific Aim 1 
 
Demonstrate the presence of PKC isoforms in LECs and follow their temporal 
distribution between the cytosol and the plasma membrane after activation and 
depletion by phorbol esters or exposure to selective inhibitors. 
2.2. Specific Aim 2 
 
Compare by Rb uptake and K loss measurements how pharmacological 
interventions at the PKC level will affect membrane transport. 
2.3. Specific Aim 3 
 
Assess changes in mitochondrial depolarization, ATP levels and DNA 
fragmentation and correlate these changes with those in the ion transport 
mechanisms after exposing the cells to stress simulating substances such as 
phorbol esters and selective PKC inhibitors. 
2.4. Specific Aim 4 
 
Establish the functionality of at least one membrane transporter localization, that 
of the Na/K pump and its isoform, at the membrane level and verify its continued 
supply with ATP.  
2.5. Significance 
 
By altering PKC function through different pharmacological approaches, it is 
anticipated to gain insight into the transport mechanisms of the Na/K pump and 
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cation co-transporters (NKCC, KCC) upon PKC depletion.  Results could offer 
valuable insight into the transformation of LECs to LFCs and lead to additional 
treatments for cataracts and possibly even a cure. Since PKCs play crucial roles 
in the regulation of ion transporters of all tissues and cells, findings made here 
may be extrapolated to other research areas under study in biomedicine such as 
cancer and vascular atherosclerosis.  
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3. Materials and Methods 
 
3.1. Reagents 
 
3.1.1. Chemicals 
 Sodium chloride (NaCl), potassium chloride (KCl), magnesium chloride 
(MgCl2), dimethyl sulfoxide (DMSO), tris (hydroxymethyl) aminomethane (Tris), 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 70% perchloric 
acid (PCA) were purchased from Fisher Scientific (Fair Lawn, NJ).  Calcium 
chloride (CaCl2) was purchased from J.T. Baker Chemical CO (Phillipsburg, NJ).  
Glucose and 3-[N-morpholino] propane sulfonic acid (MOPS) were acquired from 
Sigma Chemicals (St.Louis, MO).  Rubidium chloride (RbCl) was obtained from 
Alfa Aesar (Ward Hill, MA) and rubidium nitrate from Johnson Matthey Materials 
Technology U.K. (England).  Horse serum, 0.05% trypsin, and medium 199/EB 
SS were purchased from Hyclone laboratories Inc (Logan, Utah) while KGM-2 
and Fetal Clone III were procured from Lonza (Walkersville, MD). Gentamicin 
reagent solution and cesium chloride (CsCl) were purchased from Invitrogen 
(Carlsbad, CA).  
3.1.2. Inhibitors 
 Chelerythrine chloride was purchased from LC Laboratories (Woburn, 
MA), ouabain from Santa Cruz Biotechnology (Santa Cruz, CA), bumetanide and 
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12-O-tetradecanoylphorbol-13-acetate (TPA) was from Sigma- Aldrich (St.Louis, 
MO).  
  3.1.3. Molecular and Immunological Tools 
 M-PER mammalian protein extraction kit, HALT protease inhibitor cocktail 
kit, and Bicinchoninic acid (BCA) protein assay reagents A & B were purchased 
from Pierce Biotechnology (Rockford, IL).  Primary antibodies and blocking 
peptides against PKCα, ε, δ, ζ isoforms were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA).  Secondary antibodies included horseradish 
peroxidise-coupled donkey anti-rabbit IgG and Cy3-conjugated donkey anti-rabbit 
IgG both purchased from Jackson Immunoresearch Laboratories (West Grove, 
PA). Na/K ATPase α and phosphoserine (pSer) primary antibodies were 
purchased from Santa Cruz biotechnology while the NKCC1 primary antibody 
was obtained from cell signalling technology (Danvers, MA). Cell death ELISA kit 
and Lumi-light western blotting substrate were obtained from Roche Applied 
Science (Indianapolis, IN).  EZ-Link Sulfo- NHS Biotinylation Kit was purchased 
from Pierce Biotechnology (Rockford, IL). Mitotracker CMX-ROS was purchased 
from Invitrogen (Carlsbad, CA).  Vectashield mounting medium with DAPI for 
fluorescence was bought from Vector Laboratories (Burlingame, CA).  Tissue 
culture plates were procured from Costar (Corning, NY) and from Sarstedt 
(Newton, NC) and 75cm2 culture flasks from Fisher Scientific (Fairlawn, NJ). 
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3.2. Ion Flux Solutions 
 
 A flux solution is used to introduce outside Rb (K) to the cell.  It’s used to 
measure the amount of K entering the cell and allows for the comparison of the 
control cells vs treated cells.  Balanced salt solution (BSS) consisted of 20 mM 
Hepes-Tris, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and NaCl as 
a filler salt.  BSS has an osmolarity of 300 mosM, measured using an Advanced 
Micro-osmometer model 330 from Advanced Instruments (Norwood, MA) and a 
pH of 7.4 at 37⁰C.  10 mM RbCl flux solution consisted of 20 mM Hepes-Tris, 10 
mM RbCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 0.1% bovine serum 
albumin (BSA), and NaCl as a filler salt with an osmolarity of 300 mosM and a pH 
of 7.4 at 37⁰C.  The isosmotic washing solution consisted of 10 mM MOPS/Tris 
and MgCl2 as a filler salt yielding an osmolarity of 300 mosM and a pH of 7.4 at 
room temperature.  The cation extraction solution consisted of 5% PCA and 4 
mM CsCl.  1 M NaOH was used for protein dissolution.    
3.3. Cell Culture 
 
 FHL-124 cells were grown in medium 199/EB SS containing 72% KGM-2, 
5% fetal clone III, 5% horse serum, and gentamicin.  Cells were grown to 
confluence in a 75 cm2 flask and in an incubator containing 5% CO2 and 95% air 
at 37⁰C.  Once confluent, the cells were trypsinized using 3 ml of 0.05% trypsin 
and incubated for 2 min at 37⁰C.  The cell/trypsin mixture was added to more 
growth medium and centrifuged at 700 rpm for 5 min.  The pellet was re-
suspended in fresh medium and its cells counted using a haemocytometer. The 
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cells were then plated into 100 mm petri dishes, 6 well plates, or 12 well plates 
and grown until they reached 100% confluence.  
3.4. Measurement of Ion Fluxes 
 
 Intracellular rubidium uptake (Rbi) and K content (Ki) in nmoles/mg protein 
were measured according to Lauf et al. (2008).  FHL-124 cells were grown to 
confluence in 12 well plates and washed with the warm (37⁰C) BSS-NaCl 
solution stated above at room temperature.  Cells were exposed to the 
appropriate treatments for anywhere between 0-6 h according to specific 
protocols.  After treatment, the Rb-Cl flux media mentioned above was added to 
the cells. The influx was terminated by removal of flux media and was followed by 
five washes in the MgCl2 solution at room temperature.  Ions were extracted 
using a mixture of 5% PCA and 4 mM CsCl for 15 min at 4⁰C and then 1 N NaOH 
was added to the plates for 30 min at room temperature for protein dissolution.  
Protein was measured using the BCA protein assay while Rbi and Ki were 
measured using a Perkin-Elmer 5000 Atomic Absorption spectrophotometer 
(Perkin-Elmer, Boston MA).  After absorbance was measured, Ki and Rbi were 
calculated as described by Adragna 1991.   
3.5. Western Blot 
 
 FHL-124 cells were grown to 100% confluence in 100 mm tissue culture 
plates according to Chimote et al. (2010).  Cell lysis was performed using M-
PER® mammalian protein extraction kit in the presence of Halt™ protease 
inhibitor cocktail according to manufacturer’s instructions.  The cell lysates were 
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combined in a 1:1 ratio with 2x Laemmli SDS electrophoresis sample buffer 
(Sigma Aldich, St.Louis, MO).  5µg of protein was loaded into each lane of a 
7.66% polyacrylamide gel for 1.25 h run in a Mini-V 8.0 Vertical Gel System 
(GIBCO®BRL, Invitrogen, Carlsbad CA) at room temperature and with a current 
of 100 mA.  The protein bands were transferred to polyvinylidene difluoride 
(PVDF) (Millipore Ireland Ltd) membranes at 4⁰C overnight with the current set to 
90 mA.  The membrane was placed in a blocking solution consisting of 10% milk 
and TBST (10 mM Tris-Cl, 150 mM NaCl, and 0.05% Tween-20) for 1 h at room 
temperature and moderate shaking on a plate rocker.  The membrane was 
incubated overnight at 4⁰C with primary antibodies against the various PKC 
isoforms in dilutions ranging from 1:200 to 1:1000. Primary antibody dilutions for 
Na/K ATPase α, pSer, and NKCC1 were 1:500, 1:200, and 1:200 respectively. 
Next, the membrane was incubated with HRP-coupled donkey anti-rabbit IgG or 
anti-mouse secondary antibody in a 1:3000 dilution for 1.5 h at room temperature 
and was washed several times with TBST.  The membrane was coated with 
Lumi-Light Western Blotting Substrate for 45 seconds and the protein bands 
were analysed using a Fuji Las-4000 imaging system.   
3.6. BCA Protein Assay  
 
 Samples of 12.5 µL were loaded into a 96 well plate and combined with 
BCA™ Protein Assay Reagent A and B according to manufacturer’s instructions.  
The plate was incubated at 37⁰C for 30 min and the developed color quantified 
using Labsystems multiskan MCC/340 plate reader.   
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3.7. Immunofluorescence Staining and Fluorescence Microscopy 
 
 FHL-124 cells were grown on an 8 well Lab-Tek Chamber Slide™ (NUNC) 
as described by Chimote et al. (2010).  Once confluence was reached the cells 
were fixed with a 4% paraformaldehyde solution containing 0.1% saponin for 
permeabilization for 30 min at 4⁰C.  Chambers were washed with 1X PBS and 
blocked with 3% normal goat serum for 1 h at 4⁰C and then incubated overnight 
at 4⁰C with primary antibody in a 1:200 dilution.  The cells were then incubated in 
a 1:250 dilution of a CY3-conjugated secondary antibody for 90 min in a light-
protected box at 4⁰C.  Cells were washed with 1X PBS and mounted with 
Vectashield™ containing DAPI and analysed using the Nikon Eclipse E400 
epifluorescence microscope.  Objectives of 20X, 40X, 60X, and oil immersion 
100X were used.  Images were taken with a Canon rebel camera and over 
layered using GIMP 2.6 imaging software.  
3.8. Cell Death Detection ELISA 
 
 Cell Death Detection ELISA Kit (Roche Applied Science Indianapolis, IN) 
was used for this experiment.  Protocol was adapted from (Chimote et al., 2010 
and Kulkarni et al., 2006) and changed to prevent the use of trypsin.  FHL-124 
cells were grown to confluence in 6 well tissue culture plates and underwent a 
treatment of 50 µM CET for 0-3 h at 37⁰C.  Following CET incubation, the cells 
were placed in incubation buffer for 30 min, scraped into new tubes,  and 
centrifuged at 16,000 x g for 10 min. ELISA was performed on the supernatants 
according to manufacturer’s instructions using an anti-histone antibody and anti-
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DNA peroxidise-conjugated antibody.  Cell death was evaluated in the 
Labsystems multiskan MCC/340 plate reader (ThermoFisher Scientific) at 405 
nm and 490 nm for reference.   
3.9. ATP Determination 
 
 Protocol was adapted from Brown 1982.  FHL-124 cells were grown to 
confluence in 12 well plates as described by and treated with 50µM CET for 0-30 
min at 37⁰C.  The rest of the experiment was done on ice to keep solutions and 
samples cooled at 0-4⁰C to minimize ATP hydrolysis.  Cells were extracted with 
5% PCA and combined with d-H2O to give a 1.49 x dilution.  A KOH mixture (200 
mM Hepes, 100 mM KCl, and 700 mM KOH) was added to give a pH of 7.0-7.4.  
Samples were analysed in a Beckman LS 6000TA Scintillation Counter (Brea, 
CA) after vials were set up with combination buffer (20 mM Hepes, 25 mM MgCl2, 
and 5 mM Na2HPO4) and luciferin-luciferase from ground-up firefly lanterns 
(Sigma Aldrich).  
3.10. Mitochondrial Depolarization Detection  
 
 FHL-124 cells were plated at 16 x 104 cells/well in an 8 well Lab-Tek 
Chamber Slide™ (NUNC).  Cells were treated with either 50µM CET or BSS as 
the control and at concentrations (nM) of 50, 100, 200, and 300 of Mitotracker® 
Red CMXROS for 30 min at 37⁰C according to manufacturer’s instructions 
(Invitrogen, Carlsbad CA).  After treatment, cells were fixed with a 4% 
paraformaldehyde solution for 15 min at 4⁰C and then mounted with Vectashield 
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containing DAPI.  Cells were observed using the Nikon Eclipse E400 
epifluorescence microscope.  Objectives of 20X, 40X, 60X, and oil immersion 
100X were used.  A decrease in the red staining is an indication of membrane 
depolarization.  Images were taken and processed as described in 3.7. 
3.11. TPA Depletion Studies 
 
 FHL-124 cells were grown to 100% confluence in 60 mm culture dishes.  
Cells were incubated with BSS and 100 nM TPA for 0-6 h at 37⁰C (Thodeti et al., 
2001).  Cells were washed and lysed using M-PER® mammalian protein 
extraction kit in the presence of Halt™ protease inhibitor cocktail according to 
manufacturer’s instructions.  Cells were centrifuged at 16,000 x g for 10 min and 
the supernatant and pellet which was washed 3 x in BSS were analysed by 
Western blotting.   
3.12. Biotinylation  
 
 FHL-124 cells were grown to 90-95% confluence in 49 cm2 culture dishes 
according to manufacturer’s instructions (Pierce Biotechnology). Cells were 
washed quickly with ice cold PBS to prevent rounding and detachment.  Cells 
were then incubated with BSS ± 50 µM CET for 30 min at 37⁰C.  Thereafter 2 µM 
okadaic acid was added and incubated for 10 min at 37⁰C. Sulfo-NHS Biotin was 
dissolved in PBS and added to each culture dish and incubated at 4⁰C for 30 
min.  An amine buffer was then added to quench any free biotin. Cells were lysed 
and centrifuged for 1 min at 10,000 x g.  Resulting supernatant was removed and 
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pellet solubilized in a solution containing lysis buffer and 1% CHAPS.  Pellet was 
sonicated and centrifuged for 2 min at 10,000 x g.  Resulting supernatant was 
added to 1 ml of StreptAvidin, incubated at 4⁰C for 1 h, and centrifuged for 2 min 
at 5,000 x g.  50 mM DTT was added to 2x SDS and incubated for 60 min at RT 
to help elute the proteins.  After incubation, eluted proteins were centrifuged for 2 
min at 5,000 x g and resulting supernatant was analyzed by Western Blotting.   
3.13. Statistical Analysis 
 
 T-tests and one-way ANOVA were calculated using STATISTIX 7 software 
(Analytical software, Tallahassee FL) and Graphpad Prism 5 (Graphpad 
Software, La Jolla CA).  Charts and graphs were plotted using Origin 7 software 
and Origin Pro 8.5 Student Version (Origin Labs, Northampton MA). Data with p-
values < 0.05 were considered significant.  
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4. Results 
 In a previous study it was shown how the general protein kinase inhibitor 
staurosporine, by opening a voltage-dependent K (Kv1.4) channel, presumably 
through dephosphorylation, causes a fall of the intracellular K concentration 
associated with membrane phosphatidylserine externalization followed by 
apoptosis (Chimote et al., 2010). To narrow down this effect, the present study 
was aimed at the effect of pro-apoptotic PKC modulators, such as TPA and the 
selective inhibitor CET, on cation transport mechanisms in LECs hoping to 
identify a specific PKC isoform in control of the apoptotic volume regulatory Kv 
1.4 channel. From other cell systems there is ample evidence that PKCs are 
regulating primary and secondary active cation transport mechanisms (Pierre et 
al., 2002), especially the Na/K pump and the cation-chloride cotransporters 
(Liedtke et al., 2002, 2003).  
 Hence, the results address first the cellular presence of four PKC isoforms 
in LECs discussed in section 4.1, and the effect of TPA and CET on their 
distribution between the cytosol and the plasma membrane, the two main 
compartments of their functional equilibration (section 4.3).  Second, previous 
work already established the presence of the NKCC1 and KCC1, 3, and 4 
isoforms in human LECs (Misri et al., 2006), however, it was unknown which of 
the 4 Na/K pump catalytic α subunits occurs in these cells. Therefore, to 
complete the picture, also the Na/K pump isoform responsible for primary active 
Na/K exchange transport was immunologically determined.  Third, based on the 
time course of the PKC changes in response to the two pharmacological 
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interventions, subsequent ion flux studies were designed to capture and explain 
their changes from steady state requirements that ultimately may or may not lead 
to apoptosis (sections 4.9).  Fourth, the significant effects of one of the two PKC 
modulators on the Na/K pump and NKCC activities, required additional 
approaches to clarify the role of PKCs in the maintenance of steady state 
functions of these transporters, or their failure potentially preceding apoptosis. 
The results of this work thence constitute new insights into the functioning of 
Na/K pump and cation chloride cotransporters in human LECs which are 
compromised by a challenge with pro-apoptotic PKC inhibitors. 
  
4.1. Characterization of PKC isoforms in FHL-124 cells 
 
 Many PKC isoforms have been identified and classified according to their 
structure and second messenger requirements (Mellor et al., 1998, Gutcher et 
al., 2003, Thodeti et al., 2001, Steinberg 2008). The present study looks at 4 
different PKC isoforms, 2 of which are pro-apoptotic (δ, ζ) and 2 are anti-
apoptotic (α, ε). Figure 1 shows the Western blot analysis of each PKC isoform 
tested with its blocking peptide to compete for the epitope which the primary 
antibody recognizes.  This ensures that the primary antibody can no longer bind 
to the epitope and hence constitutes a negative control.  The WB shows that 
FHL124 cells possess PKC isoforms α, ε, δ and ζ.  Protein bands of ~78 kDa 
molecular weight were obtained and abolished (α, , δ) or attenuated (ζ) by 
incubation with isoform-specific peptides against which the antibodies were 
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raised.  Figure 2A shows the presence of the four PKC isoforms by 
immunofluorescence (IF) staining.  Strongest IF staining occurred with anti-PKC 
and was primarily cytoplasmic diffuse (α, ε) and punctuate (δ and ζ), and 
generally was abolished (α, , δ) or attenuated (ζ) by the blocking peptides 
(Figure 2B). 
4.2. Na-K-ATPase α isoforms present in FHL-124 cells 
 
 The Na-K-ATPase enzyme consists of the catalytic α and the supportive 
and regulatory β and γ subunits (reviewed in Lauf and Adragna, 2011).  The α 
subunit exists in 4 isoforms, α1-α4 (Pierre et al., 2002, Sottejeau et al., 2010).  To 
test which α isoforms were present in the FHL-124 cells, whole cell extracts were 
prepared as outlined in Materials and Methods and sent for analysis by Yoann 
Sottejeau and Qiming Duan at the University of Toledo. Figure 3 shows the WB 
of FHL-124 cells and of B3 lens epithelial cells, another but SV-40 transformed 
cell line, compared to the positive control of rat brain homogenate.  Figure 3A 
shows that both cell lines contained a single band at 100 kDa of the Na-K-
ATPase α1 but not the α2 or α3 isoforms (Figure 3B & 3C).  
 Previous work from this laboratory has shown by western blots, and by 
reverse transcriptase and polymerase chain reaction (RT-PCR),  the expression  
of NKCC1 and KCC1, 2, 3 and 4 isoforms in FHL124 cells and hence these data 
are not reproduced in this section (Misri et al., 2006, Lauf et al., 2008).  
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4.3. Time course of the TPA effect on PKC cytosol/membrane 
distribution 
 
 The phorbol ester TPA is known to cause redistribution of PKC after 
prolonged exposure in MCF-7 human breast cancer cells (Issandou et al., 1988). 
Such TPA effects are unknown in human LECs. TPA mimics the behavior of 
DAG by binding to PKC, initially activating it, and progressively degrading the 
kinase, which alters the cell signalling cascade (Kolb et al., 2004).  A TPA dose 
response curve was not done because 100 nm of TPA was the dose used by 
Thodeti et al. (2001) to give positive results in human intestinal cells.  Figure 4 
and 5 show that TPA depleted all 4 PKC isoforms (α, ε, δ, ζ) after 2 h of 
treatment by removing the PKCs from the cytosol and redistributing them into the 
membrane particulate fraction.  In the membrane, PKCα was increased at 2 h by 
600% and then decreased thereafter.  After remaining constant from 0-4 h, PKCε 
increased to almost 400% from 4-6 h. PKCδ and PKCζ were not completely 
removed from the cytosol. In the membrane, PKCδ increased and decreased in 
staining-intensity throughout the 6 h treatment while PKCζ gradually decreased. 
These findings are consistent with that of Thodeti et al. (2001) in human intestinal 
cells who studied the effect of TPA on the cytosolic expression of PKC ε.   
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Figure 1- Presence of four PKC isoforms in FHL 124 cells  
Western blot of protein extracts from FHL 124 cells for the presence of various 
PKC isoforms using rabbit polyclonal IgG 1⁰ antibody (Ab) and blocking peptides. 
Lanes 1 and 2 are a double staining for   (A) PKCα 1:2000.  (B) PKCε 1:500.  (C) 
PKCδ 1:200.  (D) PKCζ 1:500. 2⁰ Ab was horse radish peroxidase (HRP)-
coupled donkey anti-rabbit IgG (1:3000). Lanes 3 and 4 are a double staining of 
the primary antibody with its blocking peptide for each isoform.  
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Figure 2- Evidence of PKC isoforms in FHL 124 cells. FHL 124 cells fixed in 
4% paraformaldehyde and 0.01% saponin revealed the presence of (A) PKCα, ε, 
δ, ζ(100x magnification). (B) Primary antibody + blocking peptide (60x 
magnification)(by immunofluorescence microscopy. DAPI for nuclear stain (blue) 
and CY3-conjugated donkey anti-rabbit antibody (red) as 2⁰ antibody at a 1:250 
dilution.   
A 
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Figure 3:  Expression of Na/K-ATPase α isoforms in HLEC.WB analysis of 
FHL-124 cells and B3 human lens epithelial compared with rat brain homogenate 
for the presence of Na-K-ATPase α isoforms.  FHL-124 cell extracts prepared as 
outlined in Material and Methods were kindly analyzed by Yoann Sottejeau and 
Qiming Duan at the University of Toledo.  Protein extracts of 25 µg were used. 
Isoforms A) α1, B) α2, C) α3. 
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Figure 4: Long term TPA effect on PKC distribution in the cytosol and 
membrane. FHL cells were treated with 100 nM TPA for times 0, 2, 4, and 6 h.  
Thereafter, cells were lysed and their supernatants (lane 2-5) and washed 
membrane pellets (lane 6-9) analyzed by WB. Identical protein amounts (4µg), 
1⁰Ab concentration (1:200), and 2⁰Ab concentration (1:3000) were used per gel.  
(A) PKCα.  (B) PKCε.  (C) PKCδ.  (D) PKCζ. 2⁰ Ab was (HRP)-coupled donkey 
anti-rabbit IgG (1:3000). 
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Figure 5: Densitometry scans of membrane and cytosolic PKCs after TPA. 
Densitometry x Area (D x A) were calculated from Figure 4 by multiplying the net 
intensity and interior area (pixels) of the gel bands and dividing by 108.  (A) 
PKCα.  (B) PKCε.   (C) PKCδ.  (D) PKCζ.   
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4.4. Effect of long term exposure to TPA on cation transport in FHL124 
cells. 
 
 Previous work established the initial velocity conditions for Rb uptake in 
the presence and absence of 0.1 mM ouabain and 0.01 mM bumetanide, the 
specific Na/K pump and selective NKCC inhibitors, respectively, in FHL124 cells 
(Lauf et al., 2008). In addition, using Cl replacement by NO3 in the presence of 
ouabain and bumetanide, the KCC activity was determined from the difference of 
the Rb influx in the presence and absence of Cl.   Applying this technique, 
FHL124 cells were first incubated with 100 nM TPA for 6 h, the dose and  
maximum time period used in the WB experiments, to assess any major change 
in the total Rb influx, and its subcomponents, the Na/K pump, the NKCC and the 
KCC activity. We also measured cellular K content at the end of the incubation 
times to assess whether any pre-apoptotic K loss had occurred. In addition to 
TPA, the selective PKC inhibitor CET was present for 20 min at the beginning 
and the end of the long term TPA incubation. A more detailed description of the 
short term effects of CET is given in section 4.7. 
 In order to assess whether any cell loss due to apoptosis occurred, the 
total protein was determined in all experiments henceforth described in each well 
that was subsequently analyzed for its ionic composition. Figures 6A and B 
reveal the long term action of TPA on protein and K content in FHL124 cells 
within a time frame that led to a redistribution of the PKC isoforms from the 
cytosol to the membrane (see Figure 5).  
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 Figure 6A shows that 6h exposure in the absence of 100 nM TPA (control) 
led to ~ 20% loss of total protein that was only significantly different from the BSA 
zero pre-incubation in the absence of any inhibitor (None) and presence of 
ouabain, but not when both (ouabain + bumetanide) were present.  When the 
incubation was carried out for 6 h with TPA, all three conditions (None, ouabain, 
ouabain plus bumetanide) were significantly different from the BSA zero time 
control but not from the 6 h control. Thus long term incubation per se lowered the 
protein content, i.e. led to cell loss, which was not further augmented by the 
presence of TPA. The additional presence of CET had no further significant effect 
whether CET was applied before or after the 6 h incubation in presence or 
absence of TPA. 
 Figure 6B reveals that the cellular K content also fell in the 6 h control as 
compared to the zero time BSA control which is expected if cells are lost due to 
prolonged incubation. However, TPA did not change this outcome, indicating that 
6 h incubation with TPA did not lead to cell loss. In contrast, the addition of 50 
µM CET, while not affecting at all the 20 min K content of the zero time BSA 
(except in the presence of ouabain and bumetanide), caused a further loss of K 
totalling 33% when added after 6 h of TPA treatment (compare TPACET v s 
TPA) which was real since the protein concentration did not change (see Figure 
6A).  Thus 6 h TPA treatment had little effect on cellular K, but when followed by 
CET exposure for 20 min, cell K content fell significantly. This finding is 
consistent with K loss preceding protein loss, and hence may anticipate 
apoptosis at subsequent times as shown earlier (Chimote et al., 2010). 
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Figure 6: Effect of TPA and CET treatment on total protein content and Ki 
FHL cells were incubated at 37⁰C in the presence and absence of 0.1 mM 
ouabain, and (ouabain + 10 µM bumetanide). Note that the y-axis scales are 
different for each panel. A) Protein (mg/well) was measured by BCA assay and 
B) cell K (nmol Ki/mg protein) by atomic absorption spectrometry, at 20 min.  
BSA: Incubation with BSA for 30 min.  BSACET: Pre-incubation with BSA for 10 
min followed by 50 µM CET for 20 min.  Control:  6 h incubation in BSS.  
ContCET: 6 h BSS followed by 50 µM CET for 20 min.  TPA: 6 h incubation in 
BSS with 100 nM TPA.  TPACET:  6 h 100 nM TPA followed by 50 µM CET.  
Thereafter, cells were incubated at 37⁰C for 20 min in a flux solution containing 
10 mM Rb (see Materials and Methods).  Means ± SD for n=4.  
* p<0.05, ** p<0.01, *** p<0.001 
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 Figure 7 shows Rb influx before and after 6 h treatment with TPA with and 
without CET. Table 1 computes the statistical significances for the data shown in 
Figures 6 and 7.  In Figure 7A, compared to the zero time BSA data, the total Rb 
influx before 6 h TPA was greater which was due to a significant increase of Rb 
influx in the presence of ouabain without a substantial change in the bumetanide 
inhibition. This means that the NKCC activity, shown in Figure 7B, was 
significantly augmented by 75%.  After 6 h TPA exposure both total (none) and 
ouabain-insensitive (ouabain) Rb influxes were significantly reduced as 
compared to the 6h control values, meaning that primarily the NKCC activity was 
reduced to 35% of the 6h control value as shown in Figure 7B.  Addition of CET 
after 6 h incubation in control medium also reduced total and ouabain-insensitive 
Rb influx, suggesting effective inhibition of NKCC by 45% rather than the Na/K 
pump, as seen in panel B. However, after 6 h TPA treatment, CET reduced 
primarily the total Rb influx (panel A) which led to a greater than 85% inactivation 
of NKCC (see Figure 7B).  
 Figure 7C amplifies the Rb influx data of panel A in the presence of 
ouabain and bumetanide, i.e. the Rb inward leak flux through K channels and 
KCC. Note that whereas 6 h TPA had no effect on this parameter, the addition of 
50 µM CET for 30 min either to the zero time BSA samples, or to both the 6h 
control or 6 h TPA treatment reduced the "leak" Rb influx  significantly by 36%.   
 Thus the effect of TPA was primarily on the NKCC and not on the Na/K 
pump activity in these experiments. The CET-sensitive Rb influx difference was 
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independent of the time of application and, as shown below, was explored further 
to identify whether KCC or K channels were affected by this drug. 
         The experiment in Figure 7 was done in the absence of CO2 which could 
have caused a change in pH, cell volume and hence greater NKCC transport 
activity.  To test this, the cells were treated with 50 µM CET and 100 nM TPA in 
the presence of CO2 for 6 h, however, no difference was found when the results 
where compared to the cells incubated without CO2 (data not shown).  To test 
whether BSA was having an effect on the K content and the Rb flux, an 
experiment was designed to replace the BSA with BSS.  The results of this 
experiment are displayed in Figure 8 and 9.  As in Figure 7, so shows Figure 8A 
no difference in total protein content and Figure 8B CET reduced the K content in 
controls and after 6 h TPA significantly as seen before in Figure 7B while TPA 
had no effect.  Comparing Figures 9A, B, and C, CET inhibited the Na-K-pump 
activity by 47% after 30 min but after 6 h there was only a slight decrease in 
activity.  However, TPA decreased NKCC activity by 70% and when TPA was 
combined with CET, the NKCC was again inhibited by almost 80%.  CET caused 
a decrease in the leak while TPA had no effect.  These results suggest CET may 
have caused an initial and marked effect on the Na/K pump while TPA a more 
prolonged effect on the NKCC.  Comparing the zero time BSA data with the 6h 
control another important conclusion can be drawn, namely that simply exposing 
FHL124 cells to 6 h in BSA at 37 oC reduced significantly the Na/K pump-
mediated flux to levels comparable to those seen with CET at zero time. 
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Figure 7: Effect of TPA and CET treatment on Rb influx.FHL cells were 
incubated at 37⁰C in the presence and absence of 0.1 mM ouabain and (ouabain 
+ 10 µM bumetanide). A) Cellular Rbi (in nmol Rbi/mg protein) was measured by 
atomic absorption spectrometry after 20 min. B) Na/K pump, NKCC and C) Leak 
were calculated from the results of Rbi in A).  BSA: Incubation with BSA for 30 
min.  BSACET: Pre-incubation with BSA for 10 min followed by 50 µM CET for 
20 min.  Control:  6 h incubation in BSS.  ContCET: 6 h BSS followed by 50 µM 
CET for 20 min.  TPA: 6 h incubation in BSS with 100 nM TPA.  TPACET:  6 h 
with 100 nM TPA followed by 50 µM CET. Thereafter, cells were incubated at 
37⁰C for 20 min in a flux solution containing 10 mM Rb (see Materials and 
Methods).  Data are means ± SD for n=4. * p<0.05, ** p<0.01, *** p<0.001 
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Figure 8: Effect of TPA and CET treatment on total protein content and Ki. 
FHL cells were pre-incubated at 37⁰C in the presence and absence of 0.1 mM 
ouabain and (ouabain + 10 µM bumetanide). A) Protein (mg/well) was measured 
by BCA assay and B) cellular K (in nmol Ki/mg protein) by atomic absorption 
spectrometry.  BSS: Incubation with BSS for 30 min.  BSSCET: Pre-incubation 
with BSS for 10 min followed by 50 µM CET for 20 min.  Control:  6 h incubation 
in BSS and ContCET followed by 50 µM CET for 20 min. TPA: 6 h incubation in 
BSS with 100 nM TPA and TPACET followed by 50 µM CET.  Cells were then 
incubated at 37⁰C for 20 min in a flux solution containing 10 mM Rb (see 
Materials and Methods).  Data are means ± SD for n=4.  * p<0.05; ** p<0.01; *** 
p<0.001. 
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Figure 9: Effect of TPA and CET treatment on Rb influx. 
FHL cells were incubated at 37⁰C in the presence and absence of 0.1 mM 
ouabain and (ouabain + 10 µM bumetanide). A) Cellular Rbi (in nmol Rbi/mg 
protein) was measured by atomic absorption spectrometry after 20 min.  B) Na/K 
pump, NKCC and C) Leak were calculated from the results of Rbi in A).  BSS: 
Incubation with BSS for 30 min.  BSSCET: Pre-incubation with BSS for 10 min 
followed by 50 µM CET for 20 min.  Control:  6 h incubation in BSS.  ContCET: 
6 h BSS followed by 50 µM CET for 20 min.  TPA: 6 h incubation in BSS with 
100 nM TPA.  TPACET:  6 h BSS with 100 nM TPA followed by 50 µM CET.  
Thereafter, cells were incubated at 37⁰C for 20 min in a flux solution containing 
10 mM Rb (see Materials and Methods).  Data are means ± SD for n=4. * 
p<0.05;** p<0.01;*** p<0.001 
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4.5 Time dependence of TPA action on Rb influx. 
 
 The preceding experiments were based on the maximum depletion effect 
of TPA on the PKC isoforms seen by WB analysis (see 4.1), and showed that 6h 
after TPA treatment NKCC was significantly inactivated and that the Na/K pump 
was less affected. Also shown was that CET in combination with TPA decreased 
further NKCC and the Na/K pump in controls and after TPA, and diminished 
significantly the (ouabain plus bumetanide)-insensitive "leak" Rb transport. It was 
therefore of interest to first focus separately on the time dependency of the TPA 
effects on the these transport mechanisms at a much earlier time frame, and later 
on the short term time dependence of the CET effects (see section 4.7).  
 Figure 10A shows that the Na/K pump flux in the control media decreased 
gradually over a time window of 6 h and significantly by 33% at the last time point 
of 340 min, while TPA increased the Na/K pump significantly at the earliest time 
point which subsequently was followed by a similar decay to about 57% of its 
initial value with TPA. In contrast, Figure 10B reveals that the control NKCC 
activity significantly increased at early time points to some 60% at 150 min. 
Furthermore, TPA caused a 50% inhibition of the NKCC activity at the first time 
point of 10 min (zero time after TPA exposure) and  70% at 30 min following TPA 
treatment, which, however, gradually recovered  to ~75% of the initial flux in 
control media, by 6h. This finding suggests an early TPA-sensitive inhibitory 
component and a later TPA-insensitive phase leading to recovery of NKCC 
transport function. Finally, Figure 10C displays that the remaining (ouabain plus 
bumetanide)-insensitive Rb leak influx decreased significantly after 40 min in the 
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control and stayed unchanged thereafter. This Rb influx time dependence was 
exacerbated further by TPA which caused a 40%, statistically significant, 
decrease by 340 min, as calculated in Table 2. 
  
4.6. Cl-dependent Rb influxes before and after TPA and CET exposure. 
 
 The experiments with TPA and CET shown in section 4.2 and 4.3 
indicated that both reagents reduced the (ouabain plus bumetanide)-insensitive 
Rb leak influx. In order to answer the question, whether these effects are due to 
an inactivation of K channels or of KCC which earlier was shown in sheep red 
cells to be inhibited by a PKC of yet undefined isoform (Ferrell et al., 2000), it 
was important to measure the PKC inhibitor effects on Rb influx in two flux 
solutions of RbCl and RbNO3, the latter a known inhibiting anion. The Cl 
dependent K loss and leak (KCC) was calculated by simply taking the difference 
between the fluxes done in Cl and NO3.   
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Figure 10: Time-dependent effect of TPA on Rb Influx. FHL cells were treated 
with or without 100 nM TPA for 0 min to 340 min and pre-incubated for 10 min at 
37⁰C in the presence and absence of 0.1 mM ouabain and ouabain + 10 µM 
bumetanide.  Thereafter, cells were placed in a flux solution containing 10 mM 
Rb (see Materials and Methods) for 20 min.  Na/K Pump (A), NKCC (B), and 
remaining leak (C). Data are means ± SD for n=4.   * p<0.05    
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 In the experiment shown in Figure 11, advantage was taken of the K 
content determined in Cl and NO3-equilibrated LECs before and after treatment 
with 100 nM TPA for 3 h, in addition to measuring Rb influx. Figure 11A shows a 
calculated (positive on the y-axis) Cl-dependent K loss measured within 20 min in 
control BSS media that was largest in the presence of ouabain and smallest with 
(ouabain plus bumetanide) present, respectively, indicating a KCC component in 
all three conditions. However, after 3 h exposure to TPA, the calculated Cl-
dependent K loss became negative, indicating that long term incubation with TPA 
not only inhibited KCC but also activated a higher K permeability in NO3 media 
presumably due to channels. Figure 11B shows a small but significant KCC in the 
control which decreased 40% upon TPA exposure. Thus, although not 
statistically significant, TPA appeared to inhibit rather than stimulate KCC as 
predicted for a PKC-inhibited transport system (Ferrell et al., 2001, Adragna et 
al., 2006 review).     
 It was shown in Figure 7C that 50 µM CET added for 20 min prior to the 
flux inhibited by ~30% the Rb leak influx in Cl media, but it was unclear whether 
this effect is on the KCC system rather than on K channels. Figure 12A 
demonstrates that the calculated total Cl-dependent K loss, presumably due to 
KCC activity, was positive being statistically significantly lower when both 
ouabain and bumetanide were present than either in the absence of these two 
drugs (None) or in the presence of ouabain alone. Addition of CET did not alter 
significantly this result, suggesting that CET like TPA before exerted no clearly 
defined effect on KCC function, even though, like in the TPA experiment, CET 
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inhibited the Cl-dependent Rb influx through the KCC system by about 30%, 
which was statistically not significant (Figure 12B). Not shown are the total 
protein content values for TPA and CET experiments which did not change from 
the control. 
 In summary, although both long term incubation (3h) with 100 nM TPA 
and short term exposure (20 min) to 50 µM CET decreased the KCC activities 
about 30%, the findings were not statistically significant to conclude at this time 
that PKC regulates KCC in LECs. 
 
4.7. Short term CET effects on Rb influxes. 
 
 The previous experiments (sections 4.2-4.5) were to study long term 
effects of TPA to elucidate the effect of the cytosol to membrane redistribution of 
PKC isoforms on cation transport in FHL124 cells. CET has been shown to be a 
selective PKC inhibitor (Chmura et al., 2000). In the course of these experiments, 
CET was studied in combination with or without TPA to further augment the effect 
of PKC modulation on cation transport. The short term exposure to a fixed 
concentration of CET (50µM) led to the conclusion that there were some, 
perhaps significant, effects of CET on Na/K pump, NKCC and KCC fluxes, 
requiring a deeper analysis of this phenomenon by short term time- and 
concentration-dependent studies in FHL-124 cells.    
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Figure 11: Cl dependent K loss and KCC function due to TPA treatment. 
FHL cells were incubated at 37⁰C ± 100 nm TPA for 3 h in the presence and 
absence of 0.1 mM ouabain, and (ouabain + 10 µM bumetanide).  A) Cellular K 
(in nmol Ki/mg protein) and B) Rb (in nmol Rbi/mg protein) were measured by 
atomic absorption spectrometry at 20 min.  Flux solutions with RbCl and RbNO3 
were used.  Data were calculated by taking the difference of the Cl and NO3 
values.  Data are means ± SEM for n=8 for 2 independent experiments done in 
quadruplicates. * p<0.05; ** p<0.01; *** p<0.001. 
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Figure 12: Cl-dependent K loss and KCC function after CET treatment.FHL 
cells were incubated at 37⁰C ± 50 µM CET for 20 min in the presence and 
absence of 0.1 mM ouabain and (ouabain + 10 µM bumetanide).  A) Cell K (in 
nmol Ki/mg protein) and B) Rb (in nmol Rbi/mg protein) were measured by 
atomic absorption spectrometry at 20 min.  Flux solutions with RbCl and RbNO3 
were used.  Data were calculated by taking the difference of the Cl and NO3 
values.  Data are means ± SEM for n=12 for 3 independent experiments done in 
quadruplicates.* p<0.05; ** p<0.01; ***p<0.001. 
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 At variance with the experimental conditions in section 4.2-4.4, cells were 
first pre-equilibrated for 10 min in BSS and then pre-treated with ± 50 µM CET 
from 0 to 20 min and, after a 10 min flux time, total protein, K content, and Rb 
uptake were measured.  In the control (Figure 13A and C), there was a tendency 
for both K and protein content to increase with time whereas in the CET treated 
samples both cell K and protein decreased slightly, but significantly only (see 
Table 3) at 20 min. Figure 14 shows the time-dependent CET effect on Rb flux.  
In Panel A no significant changes of Rb influx in the absence and presence of 
ouabain, and ouabain and bumetanide occurred. In sharp contrast, pre-
incubation with 50 µM CET (Panel B) immediately reduced both the total Rb 
influx (after 5, 10 and 20 min 31%, 35% and 85%, respectively) and ouabain-
inhibited Rb flux without affecting the Rb leak influx in the presence of ouabain 
and bumetanide.   Figure 14C and D show that CET primarily and solely reduced 
Rb influx through the Na/K pump and the NKCC as calculated from the results of 
Figure 14A and B.  After 5, 10 and 20 min the Na/K pump was inhibited 26%, 
33% and 90%, respectively.  Likewise, the NKCC was inhibited by 25% and 95% 
at 5 min and 20 min, respectively.  The remaining leak did not change 
significantly after 20 min of CET. Statistical significances of the experiments 
shown in Figure 14 are given in Table 3. 
4.8. Dose dependent CET effects on Rb influx. 
 
 Based on the established time to reach maximum inhibition of both Na/K 
pump and NKCC fluxes, FHL-124 cells were treated with increasing 
concentrations of CET ranging from 0-50 µM for 20 min.  Figure 15A 
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demonstrates a small but significant change in protein content, however, a large 
and significant (33%) K content decrease between 10 and 30 µM CET returning 
to control levels at 40-50 µM. This finding suggests that between 10 and 30 µM 
CET, K exceeds protein loss, apparently by a K channel affected by this range of 
CET concentrations, reminding of the STP effect on Kv1.4 (Chimote et al., 2010). 
Figure 15C reveals continuous decrease of the total and ouabain-insensitive, but 
not the leak Rb influx signifying primarily inhibition of both the Na/K pump by 90% 
and the NKCC by 72% at 50 µM CET (Figure 15D). Statistics for these 
experiments are given in Table 4. These data suggest that CET, via its action on 
PKC isoforms, directly inhibited the Na/K pump and the NKCC.  
4.9. ATP production and apoptosis after CET treatment 
 
 ATP is important for driving most cellular processes like the hydrolysis of 
ATP by the Na/K pump to maintain high K and low Na inside the cell (Contreras 
et al., 1999, Lauf and Adragna, 2011).  Without ATP, the cell would practically 
shut down due to the inability of the energy dependent processes to function.  
Furthermore, all PKC isoforms utilize ATP during the phosphorylation and 
regulation of many cell processes, and inhibition of PKC has been shown to 
trigger apoptosis (Gutcher et al., 2003). The mitochondria are involved in 50-90% 
of all ATP production in a cell (Piccoli et al., 2004).  
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Figure 13: Time dependent CET effect on Ki and total protein.FHL cells were 
pre-equilibrated at 37⁰C in BSS for 10 min followed by a second pre-incubation ± 
50µM CET for 0-20 min in the presence and absence of 0.1 mM ouabain, and 
(ouabain + 10 µM bumetanide). Cells were then placed for 10 min in a fluxing 
solution containing 10 mM RbCl (see Materials and Methods) after which protein 
was measured by BCA assay (expressed as mg total protein/well) and cell K (in 
nmol Ki/mg protein) by atomic absorption spectrometry. K content in A) BSS 
Control and B) after CET. Total protein in C) BSS control and D) after CET.  Data 
are mean ± SEM for n=12 for 3 independent experiments done in quadruplicates.  
Significance at p<0.05 is represented as follows: * None; + Ouabain;  # OuaBum  
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Figure 13 
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Figure 14: Time Dependent CET effect on Rb uptake. FHL cells were pre-
equilibrated at 37⁰C in BSS for 10 min followed by a second pre-incubation ± 
50µM CET for 0-20 min in the presence and absence of 0.1 mM ouabain, and 
(ouabain + 10 µM bumetanide). Cells were then placed for 10 min in a fluxing 
solution containing 10 mM RbCl (see Materials and Methods) after which protein 
(mg total protein/well) was measured by BCA assay  and cell K (nmol Ki/mg 
protein) by atomic absorption spectrometry. Rb uptake for A) BSS control and B) 
after CET treatment. C) Calculated transport activities in BSS control, and D) 
after CET. Data are a mean ± SEM for n=12 for 3 independent experiments done 
in quadruplicates. Significance at p<0.05 is represented as follows: * None; + 
Ouabain; # OuaBum.  
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Figure 14 
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Figure 15: Dose Dependent effect of CET. FHL cells were pre-equilibrated at 
37⁰C in BSS for 10 min followed by a second pre-incubation ± 0-50 µM CET for 
20 min in the presence and absence of 0.1 mM ouabain, and (ouabain + 10 µM 
bumetanide).  Thereafter, cells were placed in a fluxing solution containing 10 
mM RbCl (see Materials and Methods) for 10 min after which protein (mg total 
protein/well) was measured by BCA assay and cell K (nmol Ki/mg protein) and 
Rb (nm/mg protein) by atomic absorption spectrometry.  A) Total Protein, B) K 
content, C) Rb uptake, D) Transporter function.  Data are a mean ± SEM for n=8 
for 2 independent experiments done in quadruplicates.  Significance at p<0.05 is 
represented as follows: * None; + Ouabain; # OuaBum. 
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 Molecular probes have been developed to offer an additional way to study 
mitochondria.  Mitotracker dyes accumulate in the active mitochondria but leak 
out, once membrane potential depolarization occurs (Piccoli et al. 2004). It has 
been shown in murine embryonic fibroblasts that CET initiates apoptosis through 
a direct effect on the mitochondria (Wan et al. 2008). Cytochrome c is released 
from the mitochondrial permeability transition pore leading to a loss of 
mitochondrial membrane potential and a decrease in ATP. Thus it was important 
to measure cellular ATP, mitochondrial integrity and apoptosis by cell death 
ELISA. 
 Figure 16 displays the results of ATP measurements in nmoles ATP/mg 
protein before and after CET treatment.  The ATP levels remained constant (or 
increased at 20 min in control but not CET-treated cells) and decreased 
thereafter at 30 min. However, this decrease is only apparent because the total 
protein was higher in the 30 min samples. Figure 17 illustrates that CET 
apparently did not affect significantly the mitochondrial membrane potential since 
there was no recognizable change in the levels of Mitotracker dye staining.  Thus 
CET appears not to have acted via mitochondria. 
 Cell death ELISA measures DNA fragmentation through a complex formed 
by the binding of a histone antibody to fragmented DNA.  Any changes in the 
complex`s absorbance (measured at 405 nm and 490 nm for reference) between 
the control and CET-treated cells is an indication of DNA fragmentation and 
apoptosis (Chimote et al., 2010, Kulkarni et al., 2006).  Figure 18 shows that over 
a time span of 3 h the 405-490 nm absorbance ratio of CET/control remained 
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around unity indicating there was no significant apoptosis after the cells were 
treated with CET. However, a small but insignificant evidence for necrosis was 
detected in the culture supernatants at 3 h.   
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Figure 16: ATP Determination after CET treatment. See Materials and 
Methods for procedure.  ATP was measured in nmoles ATP/ mg protein from 0-
30 min.  Insert: total protein (mg/well).  Data are a mean ± SEM for n=9 for 3 
independent experiments done in triplicates. * p<0.05, **p<0.01, *** p<0.001. 
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Figure 17:  Mitotracker staining for mitochondrial depolarization. FHL-124 
cells were stained with Mitotracker® Red CMXROS and treated with either 50 µM 
CET or BSS (control) for 30 min at 37⁰C.  Cells were then fixed in 4% 
paraformaldehyde and mounted with VectashieldR containing DAPI. Cells were 
observed using the Nikon Eclipse E400 epifluorescence microscope.  A) BSS 
control 60x and B) CET treated cells 40x.  
  A 
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  Figure 18: Cell death detection by ELISA. 
See materials and methods section for procedure.  Data are a mean ± SEM for 
n=9 for 3 independent experiments done in triplicates to test apoptosis.  Mean ± 
SD for n=3 for 1 experiment done in triplicates to test necrosis. * p<0.05; ** 
<0.01; *** p<0.001. 
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4.10. Biotinylation studies 
 
 It has been recently shown in Madin-Darby canine kidney (MDCK) cells 
that exposure to phorbol 12-myristate 13-acetate (PMA), which is like TPA, 
causes a cytosolic retrieval of NKCC1 after just 2.5 min, whereas the Na-K-
ATPase stayed in the membrane (Mykoniatis et al., 2010).  The purpose of this 
study was to see whether after biotinylation the Na-K-ATPase α1 subunit 
remained in the membrane after PKC was inhibited by CET.  Since the Na-K-
pump function decreased by 90% after 30 min of CET exposure, it was of interest 
to study whether, like NKCC1 in MDCK cells, the Na-K-ATPase was internalized 
into the cytosol.     
 The results displayed in Figure 19A show that, as compared to the control, 
there was a reduction of the Na-K-ATPase α1 subunit but there was still a 
significant amount of the α1 subunit present in the membrane after treatment with 
CET for 30 min, yielding strong protein bands with a molecular weight of 
approximately 100 kDa.  Figure 19B shows positive staining in the membrane 
before and after CET treatment at about 100 kDa for the phosphoserine 
antibody. Figure 19C shows positive and about equivalent membrane staining at 
about 175 kDa for NKCC1 before and after CET exposure, and a stronger 
smaller molecular weight protein band at ~100 kDa which must be a de-
compositional product of NKCC1. These data highly suggest that the Na-K-
ATPase α1 subunit only partially left the plasma membrane upon CET treatment, 
and most likely, the NKCC1 molecules not at all.  
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4.11. CET effect on PKC localization  
 
 As seen earlier in these studies, TPA caused a redistribution of PKC from 
the cytosol to the membrane when the cells were exposed to TPA.  To test if CET 
has a similar effect on the PKCs, FHL-124 cells were treated for 30 min with 
CET.  The results in Figure 20 display the CET effect on each of the 4 PKC 
isoforms tested.  Figure 20A shows that the PKCα signal, when treated with CET, 
was decreased in the cytosol and increased in the membrane. Figure 20B shows 
PKCε displaying the same characteristics as PKCα, the isoform was depleted 
from the cytosol and compartmentalized in the membrane.  Figure 20C and 20D 
show PKCδ and PKCζ being depleted from the cytosol remained in the 
membrane after CET treatment. Each isoform yielded a molecular weight of 
approximately 78 kDa. 
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Figure 19: Effect of CET on Na-K-ATPase α1 subunit, pSer and NKCC1 at 
the membrane level. 
FHL-124 cells were treated with ± CET for 30 min and subjected to biotinylation 
(see materials and methods).  The cell lysates were analysed using Western 
blotting techniques and primary antibodies of A) Na-K-ATPase α1 at 1:500 
dilution B) pSer at 1:200 and C) NKCC1 at 1:200 dilution were used.   
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Figure 20: Effect of CET on PKC isoform distribution. FHL-124 cells were 
treated ± 50 µM CET and incubated at 37⁰C for 30 min. Western blots of 
membrane and cytosol fractions for the presence of various PKC isoforms using 
rabbit polyclonal IgG 1⁰ Ab with the following dilutions:  (A) PKCα 1:200.  (B) 
PKCε 1:200.  (C) PKCδ 1:200.  (D) PKCζ 1:200. -actin was the loading control.  
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5. Discussion 
 The original  purpose of this study was to narrow down the kinases 
responsible for early membrane changes in human lens epithelial cells when 
treated with the pro-apoptotic kinase inhibitor staurosporine (STP) which causes 
early membrane changes like the activation of amino-pyridine-inhibited Kv 1.4 
channels (Chimote et al., 2010).  STP is a broad spectrum inhibitor of OH-amino 
acids and tyrosine kinases. The initial goal was to determine which type of kinase 
was responsible for these reported changes. The PKCs are serine/threonine 
kinases, known major players in many physiological processes (Gutcher et al., 
2003, Thodeti et al., 2001, Steinberg 2008). PKC isoforms are present in a wide 
variety of cell lines: Human intestinal cells, vascular smooth muscle cells, human 
leukemia T-cells, fibroblasts, human tracheal epithelial cells, chicken embryo lens 
cells, and many more (Thodeti et al., 2001, Goerke et al., 2002, Meller et al., 
1996, Goodnight et al., 1995, Liedtke et al., 1997, Berthoud et al., 2000). Two 
very different compounds targeting PKCs were chosen: 1) A long term acting 
phorbol ester, TPA, known to deplete PKCs from the cytosol binding to their C1 
domains (Brose et al., 2002) and induce their redistribution to the membrane 
(Issandou et al., 1988); and 2) CET displacing ATP at their C3 ATP binding site 
domain (Herbert et al., 1990) thus interfering with substrate transphosphorylation.  
 Selecting four PKC isoforms for their proclaimed pro- and anti-apoptotic 
properties (Gutcher et al., 2003), this study addressed their presence in FHL-124 
cells, their TPA-induced distribution from the cytosol to the membrane, whether 
treatment with TPA and CET affected membrane transport, especially cell K loss 
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and K influx measured with the K congener Rb, whether or not these 
interventions led to the development of apoptosis, and how short term exposure 
to CET changed channel K efflux, and  the Na/K pump and NKCC influx 
activities.  The key findings in this study were that either of two PKC inhibitors 
had distinct effects on K efflux and major effects on Rb influxes and its 
subcomponents, specifically the Na-K-pump and NKCC. In the end, these 
observations made here address the fundamental question whether pro-
apoptotic PKC inhibitors exert their effect to lower cellular K required for caspase 
activation and apoptosis first at the K channel level or at the Na/K pump and 
NKCC1 level, or independently at both levels.  
5.1. PKC isoforms in FHL-124 cells 
 
 This study verifies the presence of PKCα, ε, δ, and ζ in a human LEC line 
(FHL-124).  The two anti-apoptotic isoforms (α, ε) have been implicated in cell 
shape, growth, and survival (Nakashima 2002, Gutcher et al., 2003), while the 
two pro-apoptotic isoforms (δ, ζ) have been shown to be involved in cell death 
(Gutcher et al., 2003). Not an obvious fit with this classification, PKCδ, acting 
upstream, phosphorylates SPAK (Smith et al., 2008), another serine kinase 
which by phosphorylation regulates NKCC through interaction with WNK4 and 
thus regulates cell volume (Gagnon et al., 2007). PKCζ participates in the T-
lymphocyte signalling cascades (Thuille et al., 2005).  All four isoforms were 
present in the FHL-124 cells with PAGEL protein bands at ~78 kDa eradicated 
with the blocking peptides (Figure 1) and with PKCα and PKCε IF-positive 
staining more spread throughout the cytoplasm, and PKCδ and PKCζ more 
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punctuate (Figure 2). Whether the difference in staining, diffuse vs. punctuate, 
may be related to the established anti-apoptotic and pro-apoptotic PKC isoform 
properties and indicate how these PKC isoforms interact with different signalling 
cascades controlling either cell survival or cell death, remains to be seen.    
5.2. TPA and its effect on ion transport in FHL-124 cells 
 
 It is well known that long term TPA exposure causes the re-location of 
PKCs from the cytosol to the membrane (Issandou et al., 1988). Thodeti et al. 
(2001) showed in human intestinal cells a down regulation of PKCε after just 2 h 
of TPA exposure while PKCα and PKCδ remained with strong band intensity.  
The present study was designed to see how each isoform responded to 
treatment with TPA in FHL124 cells.  Figures 4 and 5 show that PKCε, like in the 
human intestinal cells, was depleted after 2 h.  However, PKCα, δ, and ζ were 
also down regulated after 2 h, thus distinguishing the FHL124 cell line from 
others. Commensurate with observations by others (Thodeti et al., 2001, 
Muscella et al., 2008, Crabos et al., 1991, Issandou et al., 1988), loss of PKCs in 
the cytosol is accompanied by their increased presence in the membrane. This 
may be explained by assuming that the phorbol ester, by binding to the C1 
domain of these PKCs, attracts the enzymes preferentially to the plasma 
membrane (Brose et al., 2002). This conclusion is consistent with the 
redistribution of the isoforms from the cytosol to the membrane seen by Issandou 
et al. (1988). It is likely that, once in the membrane, these PKCs are removed by 
another process, possibly by endocytosis, hydrolyzed by lysosomes, or 
externalized by exocytosis.  PKCα seemed to be the most abundant of the 4 
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isoforms since it gave the strongest band signal.  The high levels of PKCα in the 
membrane may mean it is also in the FHL124 cell line involved in the regulation 
of the Na-K- pump through phosphorylation of Ser-18, which was proposed by 
Feschenko et al. (2000).  PKCα and ε are more cytosolically based, as seen in 
the IF studies, while PKCδ and ζ may be more membrane based.  In the WB 
results (Figure 4) PKCδ- and PKCζ-positive protein bands are also seen near the 
top of the gels.  One reason for this may be that these 2 isoforms aggregate with 
themselves or other proteins to form homo-or hetero-polymers. PKCδ is such a 
candidate and may combine with the NKCC1 isoform and therefore is in control 
of this transporter through SPAK, as previously shown (Smith et al. 2008, 
Gagnon et al., 2007).   
 Based on the observed PKC redistribution from the cytosol to the 
membrane after 2 h of TPA exposure, the transport functional properties of 
FHL124 cells were studied when introduced to TPA for long periods of time.  Flux 
studies were designed to measure the K content and Rb uptake 6h after the 
addition of the phorbol ester.  Six hours after exposure to TPA, there was no 
significant cell loss since both the total protein and K content principally remained 
unchanged, however, Rb influx was significantly altered, specifically the activity 
of the NKCC.  NKCC activity was inhibited by ~75% when compared to the 6 h 
control while the Na/K pump wasn’t affected.  Cl dependent studies indicate that 
TPA caused, although not significant, inhibition of KCC by ~40%. This finding 
needs to be followed up further because earlier work on red blood cells from this 
laboratory implicated a yet unknown PKC isoform to inhibit KCC in long term 
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experiments (Ferrell et al., 2000). Thus if KCC is regulated similarly across 
mammalian cells, TPA should have released this inhibition by PKC and caused a 
KCC activation, which did not happen (Figure 11).   
 Prior to discussing the long term TPA action on cation transport, it is 
important to note that just long term incubation in the absence of TPA led to a 
loss of Na/K pump activity and a gain of NKCC function in the controls (Figures 7 
and 9). There is no ready explanation for this effect other than to assume that 
perhaps some "basal" phosphorylation of these systems is altered by mere 
prolonged incubation of the cells. This is not obvious for the Na/K pump, but with 
respect to the NKCC1 it could have been elicited by volume and pH changes that 
may have occurred unnoticed, certainly an issue to be followed up in future 
studies.  
 The time-dependent studies with TPA (Figure 11) revealed an early TPA-
sensitive inhibitory effect on the NKCC and a later TPA-insensitive recovery 
phase. This novel finding of a TPA-sensitive >70% inactivation of NKCC is 
consistent with the immuno-fluorescence reports of others that NKCC in T84 cells 
is retrieved from the membrane only minutes after TPA addition (Mykoniatis et 
al., 2010). The loss of NKCC function could be due to PKC activation leading to 
retrieval of the co-transporter from the membrane to the cytosol through a 
clathrin-mediated endocytotic pathway (Mykoniatis et al., 2010). Alternatively or 
concomitantly, TPA may induce PKCδ inhibition and hence dephosphorylation 
and inhibition of NKCC (Liedtke et al., 1997, Smith et al., 2008).  Another 
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possibility is that TPA binds non-specifically to and causes conformational 
changes of the NKCC interfering with its activity.   
 The second TPA-insensitive recovery phase, where NKCC activity was 
gradually increased, may be explained by the fact the cells were dividing and 
escaping the effect of TPA regenerating cells with a normal complement of 
NKCC molecules in their membranes. Protein synthesis and reinserting of NKCC 
molecules may also be occurring since no protein degradation was seen over the 
course of the TPA experiments. A comparison of Figure 5C and 10B reveals 
similarities between the two.  Figure 5C, like 10B, shows a TPA-sensitive from 0-
2 h and TPA-insensitive phase from 2-4 h in the membrane fraction. This would 
fit the notion that PKCδ is in control of NKCC1.  PKCδ may also be internalized 
by endocytosis since highest levels of the isoform were observed in the cytosol at 
2 h when the membrane PKCδ is decreased. 
 Cells regulate their volume by opposing salt transporters, especially by 
inward transport of Na, K and Cl via the NKCC, called RVI, and outward transport 
of K and Cl, called RVD (Hoffman et al., 2008, Lauf and Adragna, 2000). This 
process is inversely controlled by Cl-sensitive protein kinases and by 
phosphatases (Gillen and Forbush 1999). KCC was also inhibited by TPA (Figure 
10C). This was not expected since the two co-transporters (NKCC and KCC) are 
working in a "yin-yang" manner (as one is inhibited the other is activated) 
(Gagnon et al., 2005). This result may be cell-dependent, or both NKCC and 
KCC actually operate inversely but through different mechanisms not involving 
PKC regulation of KCC.  
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5.3. The action of CET on K loss and Rb influxes 
 
 CET is known to be a selective inhibitor of PKC (Herbert 1990, Chmura 
2000).  Thus CET was used to study the involvement of PKCs in the regulation of 
cation transport in FHL-124 cells, especially of their pre-apoptotic K fluxes 
through K channels and KCC, and K influx components, the Na/K pump and 
NKCC. CET was first used in combination with TPA to enhance further the PKC 
modulation of cation transport. CET was added for only 20 min in these long term 
studies because previous work from this laboratory (not shown here) 
demonstrated that cells treated with CET for long periods of time became 
detached from the culture plates thus making it impossible to quantify K content 
and Rb uptake. Initial results indicated that CET had some effect, although not 
always significant, on the Rb uptake and its subcomponents Na/K pump, NKCC, 
and KCC. These experiments were directional in that they provided, though 
small, first indications of CET-inhibited K influx components.   Thus a separation 
of the CET effect from the K loss and Rb influx measurements was imperative. 
 The results of the time and dose dependent studies with separate CET 
pre-incubation and subsequent K efflux and Rb influx regimes (Figures 13-15) 
demonstrate a complex relationship between K loss and Rb influx as function of 
the time and dose of CET applied. In comparison to the control, CET reduced the 
cell K content (Figure 13B) significantly at 10 and 20 min but only by ~ 10%. 
Simultaneously measured protein showed a small statistically significant 
reduction of similar magnitude (~10%) at 20 min (Figure 13D). The small loss of 
both K and protein could be explained by ~10% loss of cells. If so, then at this 
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highest CET concentration used, little activation of a K channel occurred, a 
finding at variance with the STP effect reported by Chimote et al. (2010) where 
both K and cell water were lost. In sharp contrast, 50 µM CET led within 20 min 
to a full inhibition of both Na/K pump and NKCC1 (Figure 14D), with both 
parameters not altered in the control (Figure 14C). Clearly, these data appear to 
dissociate any channel-mediated K efflux events from the K influx systems, the 
Na/K pump and the NKCC. Thus were apoptosis to occur, it would be primarily 
caused by a reduction of cellular K due to CET inhibition of the influx pathways.  
  However, a very different picture arises when comparing K loss and K 
influx responses to different CET doses. The Figure 15 independent experiment 
confirms what has been seen in Figure 13 and 14 that high CET concentrations 
dissociate between K loss and K influx. Whereas cellular K did not significantly 
change as compared to zero-CET controls, both Na/K pump and NKCC were 
completely inhibited >90% and >70%, respectively by 50 µM CET at 20 min and 
there was no effect on the (ouabain + bumetanide)-insensitive leak flux that, by 
definition, also contained the KCC activity. In contrast, the dose response study 
of Figure 15, shows a small but statistically significant protein (13%) and 
statistically highly significant cell K reduction by 35% at 10, 20 and 30 µM both 
returning to near zero-time levels at 40 and 50 µM CET (Figure 15A and B). This 
finding is first commensurate with some 13% cell loss due to removal of anoikis-
derived cells during the washing procedure, with anoikis (ανοηθης = without a 
home) being the early lifting of cells from the incubation wells, a sign of cell 
damage, and second with CET-induced K loss. In fact, the ratio of K/protein loss 
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is 2.3 suggesting that the majority of K loss must have occurred through K 
channels that are opened by CET treatment, a finding entirely consistent with the 
STP effect observed by Chimote et al. (2010). The data tell us for the first time 
that PKCs may actually regulate such a K channel. Future work needs to 
establish whether this process is inhibited by 4-aminopyridine and hence 
mediated by the Kv 1.4 channel.  The failure of higher 40-50 µM CET 
concentrations to have a similar effect on K loss as the lower concentrations then 
remains to be explained; perhaps higher CET concentrations override the low 
concentration effects reversing protein and K losses by targeting signalling 
pathways that cause inactivation of K efflux mechanisms, clearly an issue to be 
studied further in the future.   
 The second most significant results were the effects of CET on the K influx 
components measured by Rb uptake (Figure 15D). In Figure 15D, the CET dose 
dependence of NKCC appears to precede that of the Na/K pump, however, the 
IC50 values for both are not far apart from each other, being some 30 and 35 µM 
CET, respectively, however, the slopes of  Na/K pump and NKCC inactivation are 
different suggesting a mechanism of inactivation not common to both. It is well 
known that, without Na/K pump activity, the trans-membrane gradients of K and 
Na collapse and thus impair the thermodynamic requirements for the two ions to 
be moved out of or into the cell respectively by K efflux (channels, KCC) and Na 
influx mechanisms (NKCC and the Na/H exchanger), respectively. In addition, 
simultaneous changes in cellular Cl functionally affect through Cl-dependent 
phosphorylation steps for example the KCC and NKCC mechanisms.  
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 The findings in Figures 13-15 suggest several probable independent 
mechanisms of CET action summarized in Figure 21 which are physiologically 
significant in regard to the processes that initiate K changes preceding PKC 
inhibitor induced apoptosis. Comparison of the experiments in Figure 13/14 with 
that in Figure 15 suggest that CET, dependent on the concentration chosen, acts 
independently on a K channel, perhaps the Kv1.4 channel reported earlier 
(Chimote et al., 2010), and on both the Na/K pump and the NKCC1. With respect 
to the Na/K pump, it is conceivable that CET inhibits a putative PKCα-dependent 
phosphorylation of the Na/K pump causing dephosphorylation at its 3 
phosphorylation consensus sites, amongst them the serine 11 and 18 residues, 
which may be needed for activation, or after PKC phosphorylation has been 
transferred to another protein (Feschenko et al., 1995, 1997, 2000). This means 
that the Na/K pump, once inserted into the membrane must be phosphorylated in 
order to perform its catalytic activity as a Na plus K-dependent ATP-hydrolase 
(Skou 1992, Lauf and Adragna review 2011).  The difference in the slopes of 
CET inactivation (Figure 15D) then suggest that the NKCC1 inactivation is 
different from that of the Na/K pump, most likely involving the PKCδ isoform 
proposed by Liedtke's group (Smith et al., 2008) that phosphorylates SPAK, the 
enzyme that according to Delpire (Piechotta et al. 2002) is the key regulator of 
KCC1 phosphorylation and activity. It is also possible that the dephosphorylation-
induced deactivation of the Na/K pump causes the Na plus K gradients to 
collapse and thus indirectly or secondarily inhibits NKCC. However, this appears 
to be less likely since at 50 µM CET and 20 min incubation time, there was no 
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equivalent change in cellular K (compare Figure 13B and 15B). Its chemical 
composition allows for CET to diffuse across the membrane and inhibit the Na/K 
pump directly at the ATP-binding and phosphorylation site on Asp 369.  Unlike 
how PKC transfers its phosphorylation to other proteins, Na-K-ATPase is able to 
phosphorylate itself.  
 The effect of CET on the Na/K pump might mimic that of the selective 
Na/K pump inhibitor 
ouabain. Figure 21 
reveals that the 
structures of the two 
alkaloids share only 
remote similarities. 
Both drugs have 
heterocyclic phenolic 
rings: the hydrophilic ouabain, MW 584 daltons, with a cyclo-perhydro-
phenanthrine ring with a 5 carbon 3, 4, 5-hydroxylated rhamnose and a lactone 
ring with a ketose group, and the hydrophobic chelerythrine, MW 386 daltons, a 
benzophenanthridine alkaloid with a two-oxygenated ring.  Whether the 5 
member ring of CET has any affinity for the Na/K ATPase site to which the 
lactone moiety of ouabain binds, remains to be tested in experiments with 
tritiated ouabain, as shown earlier in red blood cells (Joiner and Lauf 1978).   
 Chelerythrine is known to induce apoptosis in a variety of cell lines and 
tissues tested; murine embryonic fibroblasts (Wan et al., 2008), human 
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neuroblastoma cells (Chan et al., 2003), rat cardiac myocytes (Yamamoto et al., 
2001). In most cases apoptosis develops over longer periods (hours) exposure to 
CET (Chan et al., 2003). Apoptosis occurs by either the intrinsic or extrinsic 
pathways (Fulda et al., 2006). The intrinsic or mitochondrial pathway involves 
mitochondrial release of cytochrome c (Fulda et al., 2006) a process inhibited by 
anti-apoptotic proteins of the Bcl-2 family. Chelerythrine targets the BclXL-Bak 
Bcl-2 protein family by displacing Bax a protein of said complex (Chan et al., 
2003) and thus triggers cytochrome c release and breakdown of the 
mitochondrial membrane potential with subsequent failure of aerobic ATP 
production, one of the main mitochondrial functions. Thus, using this mechanism, 
CET should have lowered ATP, the fuel of the Na/K pump. Figure 16 refutes this 
hypothesis: ATP was present at full levels during 30 min after CET addition. Thus 
it is of little surprise that application of the membrane potential monitoring 
mitotracker dye for testing mitochondrial integrity did not show significant 
differences from the control (Figure 17). 
 The apparent lack of apoptosis 3 h after CET treatment contrasts with the 
evidence of Chimote et al. (2010) of DNA fragmentation after 3 h of STP 
treatment. However, one has to bear in mind that the methodology chosen in the 
present study was different from that of Chimote et al. (2010). Because it is well 
known that trypsinization causes major membrane cation transport changes 
leading to a temporal but recoverable collapse of ion gradients (Adragna 1988), 
the ELISA method was modified to collect the cells with a scraper from the wells 
without trypsinization and re-suspending the cells in the ELISA reagents as 
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prescribed by the manufacturer. This lead to an enhanced but identical 
background in both controls and CET-treated cells, and therefore Figure 18 
displays the ratios between the two. Therefore, it is not possible to compare the 
data obtained here with those published by Chimote et al. (2010).  
 Given the fact that neither ATP nor mitochondrial function were altered 
and, in our opinion, apoptosis was not detectable, the question arose whether 
CET treatment would diminish the membrane localization of the Na/K pump in 
analogy to the reported phorbol ester effect to retrieve NKCC1 within minutes 
from the plasma membrane (Mykoniatis et al., 2010). In situ biotinylation was the 
method of choice to address this point and Figure 19 A shows beyond doubt that 
the Na/K ATPase α-1 isoform as tested by its respective antibody was present in 
the plasma membrane prior to and somewhat attenuated after CET treatment. 
However, the attenuation of the Na/K ATPase α-1 isoform protein band did not at 
all correspond to the near 100% loss of the Na/K pump activity measured at 30 
min after CET treatment. This suggests that any retrieval of the Na/K pump was 
functionally irrelevant. In addition, Figure 19C shows no difference in the 
expression of NKCC1 before and after exposure to CET. Thus neither the Na/K 
pump nor the NKCC1 proteins were retrieved during 30 min exposure to CET. 
Unlike in the TPA experiments of Mykoniatis et al. (2010) the NKCC remained in 
the membrane of CET-treated FHL124 cells, together with the Na/K pump.  
 Based on the previous experiments and the scheme developed in Figure 
22, it was predicted that if CET inhibits through a PKC controlling the Na/K pump 
activity through serine/threonine phosphorylation, there should be a difference in 
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Figure 22: Proposed CET action mechanisms. CET may exert direct and 
independent inhibition of the PKC isoforms controlling by phosphorylation various 
membrane transport systems important for cellular K homeostasis. Inhibition of 
an unknown PKC isoform causes dephosphorylation and activation of Kv 1.4 
potassium channels shown earlier to be STP-sensitive (Chimote et al., 2010). 
CET- inactivation of the Na/K pump and NKCC1 may be through PKCα or PKCδ, 
respectively, the latter acting at the level of SPAK (Smith et al., 2008)  or, 
alternatively (dotted lines), through direct interaction with the α, β, γ subunits of 
the Na/K pump and/or directly with the SPAK-NKCC1 regulation. 
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the phosphorylation levels of the Na/K pump ATPase before and after 50 µM 
CET. This "null hypothesis" was tested in the Na/K ATPase preparation collected 
through biotinylation and disproven by the finding of Figure 19 B: There was no 
difference in the expression of phosphoserine levels in the biotinylated plasma 
membrane protein fraction. If confirmed by mass spectrometry, this finding then 
appears to disprove at least the hypothesis that the PKCs cannot be required for 
phosphorylation of the Na/K pump at its tentative serine residues in lens 
epithelial cells. It is important to note that biotinylation cannot be performed on 
the PKCs since PKC is cytosolic and biotinylation is used to pick up surface 
membrane proteins.  PKC is only brought to the membrane through recruitment 
by DAG or TPA.  However, the results in Figure 20 rule out that CET failed to 
alter the membrane/cytosol distribution of the 4 PKC isoforms tested in non-
biotinylated FHL124 cells, suggesting that the drug apparently did not modify the 
interaction with its putatively phosphorylating PKC isoform. Since CET was used 
at concentrations (50 µM) much exceeding those required for biochemically 
isolated PKCs (Ki =0.7 µM) and thus must have completely inhibited intracellular 
PKC activity, the tentative conclusion is reached that CET directly interacts with 
the heterotrimeric Na/K pump complex consisting  of the catalytic α1, and the 
supportive  and γ subunits (dotted lines in Figure 22).   
  Another explanation would be that the CET effect is not only working on 
the PKCs but working on another kinase-dependent pathway like the 
extracellular signal-related kinase (ERK) pathway (Mohammadi et al., 2003) and 
therefore leading to the observation that PKC is not directly involved in the 
101 
 
phosphorylation of the Na/K pump.  Khundmiri et al. 2004 previously 
demonstrated that parathyroid hormone (PTH) causes Na-K-ATPase inhibition 
and concluded that Na-K-ATPase regulation by PTH requires phosphorylation of 
PKC and ERK (Khundmiri et al., 2004).  This would explain why CET does not 
lower phosphorylation in the biotinylated Na/K ATPase subunit, as the CET may 
initially inhibit ERK during the early time frame of 30 min and then PKC 
thereafter. Another possibility is pSer antibody cross reaction with tyrosine 
phosphates effected by tyrosine kinase. Tyrosine kinase has been proposed to 
be in regulation of Na-K-ATPase through a Src tyrosine kinase-dependent 
pathway (Tamiya et al., 2007). Finally, a remote possibility is phosphorylation of 
NKCC1 and not Na-K-ATPase. Figure 19 shows NKCC1 staining at 175 kDa and 
degradation of the cotransporter at 95 kDa.  The pSer antibody shows 
phosphorylation at both of these molecular weights.  If indeed these bands are 
due to NKCC1 phosphorylation, the initial concept that dephosphorylation of the 
Na/K pump leads to its inactivation is still very much at play.   
5.4. Summary 
 
 This study has offered some important and intriguing insight into possible 
development of cataract by taking a closer look at how PKC modulation by pro-
apoptotic agents affect cation transport in human LECs. In particular these 
studies shed light on the sequential or simultaneous effects these agents exert 
on cation transport and hence cellular K homeostasis. This study may be a model 
start for other naturally occurring PKC modifiers such as UV light and 
glycosylation due to diabetes. There are 4 PKC isoforms (α, ε, δ, ζ) present in 
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the FHL-124 cell line. Their post-translational modifications by a tumor promoting 
phorbol ester, TPA, and a selective inhibitor of PKC, CET, are important when 
trying to understand the kinetics and mechanism of ion transport in these cells.  
TPA was shown to have a prolonged effect while CET had a short term effect.  In 
our cell line, TPA was shown to redistribute the PKC isoforms from the cytosol to 
the membrane, while CET held the isoforms in the membrane. Functional studies 
with pharmacological intervention demonstrated that both TPA and CET play an 
important role in the inhibition of the Rb influx into cells.  Long term TPA 
exposure exerted its effect on the NKCC either through endocytosis (Mykoniatis 
et al., 2010) or through PKCδ down regulation (Liedtke et al., 2002) without 
causing major K loss. However, short term pre-incubation with CET increased K 
loss by 33% most likely via K channels earlier proposed preceding apoptosis. 
Apparently independent from the action on K channels, CET had a major effect 
on the Na/K pump and NKCC with a slight effect on the KCC.  The significant 
inhibition of the Na/K pump and cation cotransporters occurred without any early 
signs of apoptosis, which was shown through ATP assays, mitotracker dyes, cell 
death detection ELISA, and protein measurements.  Also shown for the first time 
in FHL124 cell line is the presence of Na-K-ATPase α1 subunit.  Biotinylation 
revealed the presence of Na-K-ATPase, NKCC1, and pSer with and without 30 
min CET treatment.  Taken together, our results suggest that PKC modulation 
through the use of pro-apoptotic agents, and dependent on their chemical nature, 
causes major early membrane changes independently affecting K channels, the 
Na/K pump and NKCC1 function preceding the onset of apoptosis.  
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5.5. Future Studies 
 
1. There was a CET-concentration dependent K loss through the opening of 
K channels, similar to the observation from this laboratory of a STP-sensitive 
Kv1.4 channel that is 4-AP sensitive. In order to confirm the K efflux was through 
the Kv 1.4 channel, 4-AP needs to be added along with the CET. A positive result 
would guide research to identify the PKC isoform that controls this Kv1.4 channel.   
2. The structure of CET shares similarities to ouabain and hence CET could 
be another direct inhibitor of the Na/K pump. To test this hypothesis competition 
experiments are indicated in which increasing doses of CET would displace a 
fixed dose of tritiated ouabain. If the result is positive, one could postulate binding 
of CET to the ouabain binding site on the pump. This could be proven on a 
stoichiometric basis with radio-labelled CET.  
3.  Treatment of LECs with CET causes Na/K pump inhibition and NKCC 
inhibition.  Older LFCs are deficient of the Na/K pumps needed to obtain 
nutrients. Instead, they rely on anion currents to get nourishment.  CET appears 
to be causing LECs to behave as if they are LFCs. This means that CET could 
serve as a model substance to explore the mechanism by which Na/K pumps are 
inactivated and remain non-functionally present throughout the LEC-LFC 
transdifferentiation. Obviously, this mechanism would contribute to understanding 
mechanisms underlying cataract formation either due to aging or diabetes. 
4. If the CET effect to inhibit both Na/K pump and NKCC can be shown to 
occur in other normal tissues and in the development of cancer, the findings 
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would be of general importance in cell physiology and pharmacology and 
contribute to the development of therapeutic measures. 
5. Another experiment that needs future work is long term CET treatment in 
regards to apoptosis, since there was no significant apoptosis after 3 h. One 
possibility is that CET blocks the apoptotic process in LECs by favouring 
blockage of the pro-apoptotic PKCs, thus actually preventing the onset of 
apoptosis. 
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7. Appendix 
 
Table 1: Statistical significance of Figure 6 & 7 data. 
- Each value compared to control (10 min control, 6 hr control) 
None 
Condition Protein Ki Rbi Pump NKCC Leak 
BSA CET  0.0422 * 0.1324 0.0037 ** 0.0837 0.0188 
* 
0.0058 
** 
Cont CET 0.9652 0.1200 0.0028 ** 0.2502 0.0004 
*** 
0.0124 
* 
TPA  0.7733 0.4820 0.0035 ** 0.3873 < 
0.0001 
*** 
0.2562 
TPA CET 0.5013 0.0070 
** 
0.0004 
*** 
0.2235 < 
0.0001 
*** 
0.0354 
* 
 
Ouabain 
Condition Protein Ki Rbi 
BSA CET  0.3204 0.3143 0.0086 ** 
Cont CET 0.4332 0.2448 0.0003 *** 
TPA  0.7984 0.0240 * < 0.0001 
*** 
TPA CET 0.1043 0.0072 ** 0.0001 *** 
 
Oua Bum 
Condition Protein Ki Rbi 
BSA CET  0.1847 0.0085 ** 0.0058 ** 
Cont CET 0.9729 0.0265 * 0.0124 * 
TPA  0.3633 0.0206 * 0.2562 
TPA CET 0.8844 0.0052 ** 0.0354 * 
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Table 2: Statistical significance of Figure 8 & 9 data. 
- Each value compared to control (10 min control, 6 hr control) 
 
 
None 
Condition Protein Ki Rbi Pump NKCC Leak 
BSS CET  0.2670 0.0026 0.0005 
*** 
0.0073 ** 0.7205 0.0425 
* 
Cont CET 0.1988 0.0112 * 0.0308 * 0.2646 0.0031 
** 
0.0028 
** 
TPA  0.1772 0.2383 0.0013 ** 0.8960 < 
0.0001 
*** 
0.0774 
TPA CET 0.4416 0.0091 
** 
0.0021 ** 0.2361 < 
0.0001 
*** 
0.0008 
*** 
 
Ouabain 
Condition Protein Ki Rbi 
BSS CET  0.3958 0.0456 * 0.4795 
Cont CET 0.9628 0.0062 ** 0.0028 ** 
TPA  0.1483 0.7950 < 0.0001 
*** 
TPA CET 0.0985 0.0021 ** < 0.0001 
*** 
 
Oua Bum 
Condition Protein Ki Rbi 
BSS CET  0.5919 0.0992 0.0425 * 
Cont CET 1.0000 0.0097 ** 0.0028 ** 
TPA  0.8145 0.7515 0.0774 
TPA CET 0.1496 0.0056 ** 0.0008 *** 
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Table 3: Statistical Significance for the time dependent CET studies of 
Figures 13 and 14. 
– Each value compared to its control at (0 min, 10 min, and 20 min) 
Condition Protein Ki Rbi Transporters 
0 min     
None 0.4534 0.1207 0.7250  
Ouabain 0.8212 0.2308 0.4177  
OuaBum 0.1116 0.0425 * 0.0005 ***  
Pump    0.4383 
NKCC    0.0004 *** 
Leak    0.0005 *** 
 
Condition Protein Ki Rbi Transporters 
10 min     
None 0.0037 ** 0.0005 *** 0.0005 ***  
Ouabain 0.5638 < 0.0001*** 0.0342 *  
OuaBum 0.0817 0.0019 ** 0.0057 **  
Pump    0.0034 ** 
NKCC    0.1491 
Leak    0.0057 ** 
 
Condition Protein Ki Rbi Transporters 
20 min     
None 0.0044 ** < 0.0001 *** < 0.0001 ***  
Ouabain 0.0136 * < 0.0001 *** < 0.0001 ***  
OuaBum 0.0026 ** 0.0014 ** 0.0015 **  
Pump    < 0.0001 *** 
NKCC    0.0001 *** 
Leak    0.0015 ** 
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Table 4: Statistical Significance for Dose Dependent CET Studies of Figure 
15 
- Each dose vs. control at 0 uM 
 
Condition Protein Ki Rbi Transporters 
10uM     
None 0.3101 0.0003 *** 0.0697  
Ouabain 0.8105 < 0.0001 *** 0.0214 *  
OuaBum 0.6597 0.0002 *** 0.1509  
Pump    0.7320 
NKCC    0.0440 * 
Leak    0.1509 
 
Condition Protein Ki Rbi Transporters 
20uM     
None 0.1073 < 0.0001 *** 0.0214 *  
Ouabain 0.0210 * < 0.0001 *** 0.0020 **  
OuaBum 0.4445 < 0.0001 *** 0.1783  
Pump    0.9582 
NKCC    0.0051 ** 
Leak    0.1783 
 
Condition Protein Ki Rbi Transporters 
30uM     
None 0.0373 * 0.0002 *** 0.0001 ***  
Ouabain 0.3998 < 0.0001 *** 0.0001 ***  
OuaBum 0.0883 < 0.0001 *** < 0.0001 ***  
Pump    0.0023 ** 
NKCC    0.0002 *** 
Leak    < 0.0001 *** 
 
Condition Protein Ki Rbi Transporters 
40uM     
None 0.3698 0.0052 ** < 0.0001 ***  
Ouabain 0.7947 0.0254 * 0.0001 ***  
OuaBum 0.0512 0.1661 0.0004 ***  
Pump    < 0.0001 *** 
NKCC    0.0003 *** 
Leak    0.0004 *** 
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Condition Protein Ki Rbi Transporters 
50uM     
None 0.3064 0.0091 ** < 0.0001 ***  
Ouabain 0.8035 0.0236 * < 0.0001 ***  
OuaBum 0.9803 0.0002 *** < 0.0001 ***  
Pump    < 0.0001 *** 
NKCC    < 0.0001 *** 
Leak    < 0.0001 *** 
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List of Abbreviations 
 
Abbreviation Word 
TPA 12-O-tetradecanoyl-phorbol-13-acetate 
CET Chelerythrine 
PKC Protein kinase C 
NKCC Na-K-2Cl cotransporter 
KCC K-Cl cotransporter 
K Potassium 
Na Sodium 
Cl Chloride 
Rb Rubidium 
pSer Phosphoserine 
RVD Regulatory volume decrease 
RVI Regulatory volume increase 
HLEC Human lens epithelial cells 
LEC Lens epithelial cells 
LFC Lens fibre cells 
S Serine 
T Threonine 
Y Tyrosine 
4-AP  4-Aminopyridine 
Cl/HCO3  Chloride-bicarbonate exchanger 
NHE  Sodium proton (hydrogen) exchanger 
Na/H  Sodium proton exchanger 
VSP Volume set point 
ATP Adenosine tri-phosphate 
PP1 Protein phosphatase 1 
NEM N-ethylmaleimide 
SK small conductance K channel 
IK Intermediate conductance K channel 
BK Big K conductance K channel 
VSOR Volume-sensitive outwardly rectifying anion channels 
VRAC Volume-regulated anion current 
NaCl Sodium Chloride 
 SPAK Ste20 related proline/alanine rich kinase 
OSR1 Oxidative stress response 1 
WNK4 With no lysine 
AKAP A-kinase anchoring protein 
PKA Protein kinase A 
PCO Posterior capsule opacification 
PS Phosphatidylserine 
DAG Diacylglycerol 
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 Abbreviation Word 
PDK-1 3-phosphoinositide-dependent kinase 
RTK Receptor tyrosine kinases 
PLC Phospholipase C 
IP3 Inositol triphosphate 
PIP2 Phosphatidylinositol 4, 5-biphosphate 
RACKs Receptors for activated C kinases 
α Alpha 
ε Epsilon 
δ Delta 
ζ Theta 
PMA Phorbol 12-myristate 13-acetate 
MDCK Madin-Darby canine kidney 
STP Staurosporine 
MAPK Mitogen-activated protein kinase 
Ki  Intracellular potassium content 
Rbi  Intracellular rubidium content 
WB Western blot 
IF Immunofluorescence 
Ab Antibody 
1⁰ Primary 
2⁰ Secondary 
HRP Horse radish peroxidase 
DAPI  4',6-diamidino-2-phenylindole 
NO3 Nitrate 
BSS Balanced salt solution 
BSA Bovine serum albumin 
Oua Bum Ouabain + Bumetanide 
BCA Bicinchoninic acid assay 
ELISA Enzyme-linked immunosorbent assay 
RT-PCR Reverse transcription polymerase chain reaction 
γ Gamma 
β Beta 
ERK Extracellular signal-regulated kinases 
Src Sarcoma 
 
